Next Article in Journal
From Molecular to Macroscopic: Dual-Pathway Regulation of Carrot Whole Flour on the Gluten-Starch System
Previous Article in Journal
Occurrence and Exposure Assessment of Rare Earth Elements in Zhejiang Province, China
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Biocontrol Agents and Natural Feed Supplements as a Safe and Cost-Effective Way for Preventing Health Ailments Provoked by Mycotoxins

Department of General and Clinical Pathology, Faculty of Veterinary Medicine, Trakia University, 6000 Stara Zagora, Bulgaria
Foods 2025, 14(11), 1960; https://doi.org/10.3390/foods14111960
Submission received: 22 April 2025 / Revised: 28 May 2025 / Accepted: 28 May 2025 / Published: 31 May 2025
(This article belongs to the Section Food Toxicology)

Abstract

:
The relationships between mycotoxins content in food commodities or feedstuffs and the foodborne diseases is well known. So far, the available data mainly include chemical methods of mycotoxins decontamination for agricultural commodities or raw materials, including mycotoxin binders. Therefore, the possible use of some natural and cost-effective supplements such as herbs, fungi, microorganisms, or plants with powerful and safe protection against mycotoxin-induced health ailments is the main subject of this review paper. Various antagonistic microorganisms or yeast with fungicidal properties, as well as some herbs or plants that suppress fungal development and the subsequent production of target mycotoxins and/or have protective effect against mycotoxins, are deeply studied in the literature, and practical suggestions are given in this regard. The protection by degradation, biotransformation, or binding of mycotoxins by using natural additives such as herbs or plants to feedstuffs or foods has also been thoroughly investigated and analyzed as a possible approach for ameliorating the target adverse effects of mycotoxins. Possible beneficial dietary changes have also been studied to potentially alleviate mycotoxin toxicity. Practical advice are provided for possible application of the same natural supplements in real-life practice for combating mycotoxin-induced health ailments. Natural feed supplements and bioactive compounds appeared to be safe emerging approaches to preventing health ailments caused by mycotoxins. However, the available data mainly address some in vitro studies, and more in vivo experiments are necessary for introducing such approaches in the real-life practice or industry. Generally, target herbal supplements, antioxidants, or polyenzyme complements could be used as powerful protectors in addition to natural mycotoxin binders. Bioactive agents and enzymatic degradation are reported to be very successful in regard to PAT and OTA, whereas antagonistic microorganisms/fungi/yeasts have a successful application against AFs and PAT-producing fungi.

1. Introduction

Mycotoxins are metabolites produced by fungi and are often contaminants of feedstuffs and food products, thus presenting a serious danger to animal and human health. Mycotoxin-contaminated food and feed are responsible for many foodborne diseases and health problems in both animals and humans. Such foodborne diseases are often observed in developing countries, where food/feed control is not very strict due to lower standards of food quality or the absence of adequate regulations [1]. The fungi invade cereals in the field or after the harvest, and such an invasion is often unavoidable depending on target environmental conditions, such as rain at the time of harvest or undesirable conditions during the storage of grain or feedstuffs. Therefore, the contamination of food/feed with mycotoxins is often reported in various countries, and such contamination usually involves multiple mycotoxins because a single fungus or several fungi usually produce many different mycotoxins in a single food commodity or grain. Such large-scale mycotoxins contamination of feeds/foods usually leads to serious hazards to animal/human health and a significant economic burden [2,3]. Many mycotoxins are currently reported as natural contaminants, but only approximately 12 are known to pose serious health hazards to animals and humans, including aflatoxins (AFs), with aflatoxin B1 (AFB1) and aflatoxin M1 (AFM1) being the most toxic, ochratoxin A (OTA), zearalenone (ZEA), T-2 and HT-2 toxins, patulin (PAT), deoxynivalenol (DON), fumonisins (FUMs), with fumonisin B1 (FB1) being the most toxic, nivalenol (NIV), diacetoscirpenol (DAS), and ergot alkaloids. The same mycotoxins are often contaminants of human food or animal feedstuffs at dangerous concentrations, being responsible for foodborne diseases or health ailments [1,2,3]. Some mycotoxins are also found to be frequent contaminants in animal products such as milk, meat, and eggs when ingested via feedstuffs [4].
Mycotoxin exposure of animals or poultry through diet causes health problems such as decreased weight gain, poor feed conversion, refusal of feed, foodborne diseases or ailments (Figure 1) [2,5], and some target disturbances in reproductive possibilities [6,7]. In recent years, biocontrol agents [8], in addition to biopesticides derived from microbial sources (viruses, bacteria and fungi) [9], have gained great popularity due to their persistence, non-toxic nature, and specific action against target fungal species producing mycotoxins.
The known harmful effects of mycotoxins are nephrotoxic (e.g., OTA and FB1) (Figure 1C), hepatotoxic (e.g., AFB1 and OTA), neurotoxic (e.g., FB1 and DON), estrogenic (e.g., ZEA and less DON) [5], immunosuppressive (e.g., OTA, AFB1, and T-2 toxin), teratogenic and genotoxic (e.g., OTA, AFB1, and T-2) (Figure 1C,D), or carcinogenic (e.g., AFB1, OTA, and FB1) (Figure 1E,F) [10,11,12,13,14,15,16]. In addition, some secondary microbial infections [17,18], more severe progression of some microbial diseases, or even parasitic diseases, due to the suppression of humoral or cell-mediated immune responses, are often reported in mycotoxin-compromised animals [2,5].
Therefore, it is necessary to employ new ways for safe mycotoxin decontamination by using natural feed additives [19,20] or organic binders and bioactive supplements in order to safely utilize mycotoxin-contaminated feeds and foods [21,22,23,24].
Foods or feedstuffs are often reported to be contaminated with multiple mycotoxins at low concentrations, which are within the accepted European requirements that are below the maximum permitted levels; however, such multi-mycotoxin contamination, even at low concentrations, could be dangerous for animals or humans, as a consequence of synergistic or additive interactions between target mycotoxins. Therefore, the toxicity of such low levels of target mycotoxin combinations must be carefully investigated [1]. The necessary hygiene control, risk assessment, and possible hazards to the health of animals and humans should be carefully investigated to define adequate preventive or protective measures under such circumstances.
Figure 1. (A) Spontaneous case of stachybotryotoxicosis in cattle showing hemorrhages and necroses visible on the serosa and under the serosa of the abomasus [2]. (B) Spontaneous case of mycotoxic porcine nephropathy identified at the slaughterhouse in Bulgaria showing mottled and enlarged kidneys from pigs at 6–8 months of age (left) and normal appearance of kidneys of pig of the same age (right) [2]. (C) Malformations in newborn mice whose mothers were treated with 20 ppm OTA via the feed between day 7 and day 12 of pregnancy: astomia and anophthalmia (2 offspring on left), normal fetus (2 offspring in center), and spina bifida, incl. maxillary hypoplasia and facial cleft (1 offspring on right). (D) Monophthalmia in a mouse, whose mother was treated with 10 ppm OTA via the feed up to day 8 of pregnancy [11]. (E) Adenocarcinoma in the intestine of a rat exposed to 10 ppm OTA in its diet for 19 months, showing large gray-white neoplastic foci on the intestinal serosa protruding significantly above its surface. (F) Adenocarcinoma in the liver of a male chick exposed to 5 ppm OTA in its diet for 10 months, showing gray-white neoplasia on the liver protruding above its surface [10,14].
Figure 1. (A) Spontaneous case of stachybotryotoxicosis in cattle showing hemorrhages and necroses visible on the serosa and under the serosa of the abomasus [2]. (B) Spontaneous case of mycotoxic porcine nephropathy identified at the slaughterhouse in Bulgaria showing mottled and enlarged kidneys from pigs at 6–8 months of age (left) and normal appearance of kidneys of pig of the same age (right) [2]. (C) Malformations in newborn mice whose mothers were treated with 20 ppm OTA via the feed between day 7 and day 12 of pregnancy: astomia and anophthalmia (2 offspring on left), normal fetus (2 offspring in center), and spina bifida, incl. maxillary hypoplasia and facial cleft (1 offspring on right). (D) Monophthalmia in a mouse, whose mother was treated with 10 ppm OTA via the feed up to day 8 of pregnancy [11]. (E) Adenocarcinoma in the intestine of a rat exposed to 10 ppm OTA in its diet for 19 months, showing large gray-white neoplastic foci on the intestinal serosa protruding significantly above its surface. (F) Adenocarcinoma in the liver of a male chick exposed to 5 ppm OTA in its diet for 10 months, showing gray-white neoplasia on the liver protruding above its surface [10,14].
Foods 14 01960 g001
The FAO has reported that nearly 25% of crops in the world are affected by mycotoxins each year, and losses of approximately 1 billion tons of food products are reported each year as a consequence of mycotoxin contamination [25]. Many people worldwide are constantly exposed to mycotoxins in food products such as milk, dairy products, meat, spices, coffee, beer, wine, and various cereal products [1,3,7]. Therefore, various types of economic or social losses have been reported, which are a consequence of disease and death among animals, health ailments in humans, higher costs of veterinary treatment and health services or medical care, reduction in animal growth and productivity, increased costs of mycotoxin control and preventive measures, increased costs of research and detoxification or elimination of mycotoxins, and losses due to scrapping feedstuffs or foods [26].
Considering that chemical methods for mycotoxin decontamination can deteriorate the nutrient value of feedstuffs or food commodities, their large-scale industrial use, except for ammoniation, is perceived as impractical and potentially harmful [27]. Unfortunately, ammoniation was also found to induce undesirable changes in the nutritional quality of feedstuffs, such as a decrease in sulfur- and lysine-containing amino acids [28]. In addition, aeration of feed after ammoniation is necessary for animals to accept it. Moreover, in some countries, the use of chemicals to decrease mycotoxin levels in juices is often not tolerated by food laws. In addition, the remaining residues of such chemical compounds may provoke undesirable side effects when ingested by animals and humans via feedstuffs or food [29,30].
The use of clays as nycotoxin binders at a large-scale industrial level is also controversial because of the deteriorating nutrient value of food commodities owing to the binding of some nutrients in addition to mycotoxins. On the other hand, most clays, such as kaolin, sepiolite, and bentonite, are rarely effective against most mycotoxins, such as OTA, T-2 toxins, FUMs, and DON [5,31,32,33], with the exclusion of AFs and PAT. Therefore, natural organic binders have also been suggested for the same purpose due to their efficacy against multiple mycotoxin contaminants, as reported in most cases. Natural organic binders are also highly biodegradable, preventing possible environmental contamination [34].
Obviously, natural feed additives, natural organic binders, and bioactive supplements can be used to safely utilize mycotoxin-containing grains, feedstuffs, or foods without any subsequent health problems for animals or humans [5,35,36].
This review aims to elucidate some safe and effective ways to eliminate the most dangerous mycotoxins to human and animal health that often contaminate agricultural commodities. A risk assessment and some safe ways of risk management of such contamination using natural feed supplements, bioactive substances, or biocontrol agents will be explored in the literature to define the efficacy of such measures in the safe utilization of feed/food. The possible use of such natural feed/nutritional supplements or probiotics in practice to reduce or eliminate the toxic effects of target mycotoxins will be investigated in depth.

2. Biological Methods of Protection Against Mycotoxin Contamination

Natural feed supplements can destroy the toxicity of mycotoxins through the action of target enzymes or live microorganisms, which participate in the detoxification or biotransformation of mycotoxins. Such supplements usually attract the attention of industrial feed producers because they propose a safe and promising strategy for reducing mycotoxin exposure, which is often achieved by decreasing the bioavailability of mycotoxins [5,35,36,37]. There are various kinds of biological additives that can be used to reduce feed contamination with mycotoxins and/or for mycotoxin degradation, including microbial/fungal antagonists and mycotoxin degradation by live or dead microorganisms. A decrease in mycotoxin contamination can also be achieved by cultured extracts of yeasts and some mycotoxins that destroy enzymes or proteins, all of which are non-toxic to animals and poultry and can be easily excreted from the body [38]. Biological methods for mycotoxin detoxification can usually preserve the flavor, organoleptic properties, and nutritional quality of treated food or forages and are safer and more cost-effective than other methods for mycotoxin decontamination [39].

2.1. Protection by Biodegradation, Biotransformation, or Binding of Mycotoxins

Detoxification of mycotoxins by degradation or biotransformation is a valuable modern strategy based on enzymatic or microbial methods of mycotoxin degradation. Some microbial enzymes or enzymatic preparations may be useful for such degradations. The protective properties of the gut or ruminal microbiota in some animals can be explained by the degradation of some mycotoxins into less toxic compounds or by a disturbance in the process of mycotoxin absorption by the same microbiota [40,41,42]. In this regard, some probiotics have been developed for mycotoxin detoxification and degradation using the same microbiota or digestive microflora of target animals [43].
The enzymatic degradation of mycotoxins has not been reported to be very useful in terms of AFs, FUMs, DON, and ZEA, and these mycotoxins are often present in beer produced from maize or wheat [44]. However, partial enzymatic degradation of OTA was observed, independent of the fact that OTA is a relatively stable mycotoxin in acidic or alkaline environments. A powder of the oyster mushroom Pleurotus ostreatus was recently found to have great potential to destroy OTA via simulation of in vitro gastrointestinal digestion in the presence or absence of ground feed or cornmeal. However, this powder was reported to be ineffective against ZEA [45] (Table 1) [39,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118].
Many bacteria, fungi, and yeasts have been reported to be highly effective in OTA binding and degradation. Some strains of Stenotrophomonas nitritreducens, Sphingomonas paucimobilis, and S. asaccharolytica [70]; Bacillus amyloliquefaciens [67]; Pseudomonas aeruginosa, Stenotrophomonas sp., Silanimonas sp., Luteimonas sp., and Lysobacter sp. [39] have been found to be useful for OTA degradation. Some actinobacteria are also effective in OTA degradation and adsorption or can suppress the biosynthesis of OTA. For example, some Streptomyces sp. can degrade (approximately 20–50%) or adsorb (nearly 16–30%) OTA [56], whereas other Streptomyces sp. can suppress the gene expression responsible for OTA production by A. carbonarius [56]. Phaffia rhodozyma sp. can degrade nearly 90% of OTA within 15 days and adsorb nearly 23% of the same mycotoxin for 2 h [79]. According to some authors, the adsorption potential of microorganisms towards mycotoxins is dependent on some compounds in the cell wall, such as mannans or β-glucans [119], mannoproteins [120], and glucogalactans [58], but the culture conditions can also influence the adsorption capacity [121]. Different status of microorganisms (viable or dead) can also influence mycotoxin adsorption [59,79,85,101,122].
Some filamentous fungi such as A. Japonicus sp., A. niger sp., A. carbonarius sp. [97], A. ochraceus, A. versicolor, A. fumigatus sp., A. Clavatus sp., A. Wentii sp., Cladosporium sp., P. spinulosum sp., and P. aurantiogriseum sp. are also capable of degrading OTA [100,101,102]. In addition, various yeast strains such as Yarrowia lipolytica have been found to successfully degrade OTA [80,91].
Anaerobic Eubacterium biforme MM11 from the natural microbiota of swine intestine was also found to have a great capacity to degrade nearly 80–100% of OTA or AFB1 in the target liquid medium or corn substrate for nearly 24 h, and therefore could be used for the elaboration of some feed supplements [71].
OTA degradation is mainly realized by hydrolytic enzymes such as carboxypeptidase A [39,108]. However, OTA can also be degraded via the hydrolysis of its lactone ring [123], but the final compound in such a degradation possesses high toxicity, which is similar to that of OTA, as studied in rats [124,125].
The reported detoxification of AFs using Lactobacillus strains, such as Lactobacillus rhamnosus, was recently found to be attributed mainly to the binding of AFM1 or AFB1 [46,47]. Similarly, AFB1 detoxification in vitro by the probiotic yeast Saccharomyces cerevisiae was realized by the same mechanism as that of Lactobacillus strains (AFB1 binding) [82]. Saccharomyces cerevisiae bacteria were found to be very successful in AFB1 binding, whereas other strains such as Phoma sp., Mucor sp., Rhizopus spp. 663, 668, and 710, Trichoderma sp. 639, Trichoderma harzianum, some Sporotrichum strains, and Alternaria sp. were found to have the ability to destroy more than 65% of AFB1 content [92,93,94,95], and the Flavobacterium aurantiacum strain was found to be very successful in AFB1 removal [57].
DON was found to be transformed by Eubacterium strain BBSH 797 into the non-toxic metabolite de-epoxy-deoxynivalenol [61]. Similarly, ZEA and OTA have been reported to be detoxified by the yeast species Trichosporon mycotoxinivorans [73] via OTA cleavage into the less toxic OTα and phenylalanine [70] and ZEA transformation into non-toxic ZOM-1 [74]. In subsequent in vivo experiments, the same strains, Eubacterium BBSH 797 and T. mycotoxinivorans, were also found to detoxify the same mycotoxins [76,126]. The T. mycotoxinivorans strain was also found to meet all food safety requirements for feed supplements in the EU [75]. The commercial product Mycofix® PlusMTVINSIDE was created by Biomin GmbH (Austria) based on the potent OTA detoxification potential of T. mycotoxinivorans (MTV, 115). Subsequent experimental studies showed a strong protective effect of the same commercial product against OTA-provoked toxic effects in chicks, including poor feed conversion ratio, decreased body weight gain, and increased enzyme activity of serum aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and γ-glutamyltranspeptidase, as well as against OTA-provoked pathological damage in the liver, kidney, bursa of Fabricius, and spleen [127].
Similarly, carboxylesterase was found to destroy FUMs in the porcine intestine, as the genetic code of this enzyme was previously isolated from a soil-dwelling microorganism and subsequently cloned into Pichia pastoris (recently renamed Komagataella pastoris) [77].
Various microbial agents with potent adsorption capacity for OTA also have great potential for industrial applications in food [84,128,129]. A good example in this direction revealed that within a 90-day fermentation process, the OTA content of 4 μg/mL can be decreased by 90%, 85%, and 73% in the must of red wine, rose, or white wine, respectively, due to adsorption by S. cerevisiae [128]. Similarly, Candida intermedia 253 yeast cells included in calcium alginate magnetic beads were reported to be very effective in OTA adsorption from commercial grape juice, as more than 80% of OTA content (0.02 μg/g) was found to be adsorbed within an incubation period of approximately 48 h [84].
The yeast strain Kluyveromyces marxianus C2, isolated from porcine feces, has also been reported to decrease by more than 80% of OTA content in a YPD medium or in moldy corn [39].
An experimental study demonstrated that the PAT content in juice could be significantly decreased by up to 88% via the application of inactivated Alicyclobacillus spp. at a concentration of approximately 50 g/L [55]. PAT can also be degraded by Byssochlamys nivea (FF1-2) strain [96]. An in vitro study also demonstrated that Rhodosporidium kratochvilovae strain LS11 and Sporobolomyces sp. strain IAM 13481 are not susceptible to PAT toxicity and can degrade it into less toxic compounds such as desoxypatulinic acid and ascladiol [89].

Mechanisms of Protection and Industrial Applicability

Generally, the enzymatic degradation of mycotoxins has not been reported to be very useful in regard to AFs, FUMs, DON, and ZEA. In this regard, the reported detoxification of AFs was found to be attributed mainly to the binding process [46,47].
Some licensed probiotics containing S. cerevisiae LOCK 0140, L. brevis LOCK 0944, L. plantarum LOCK 0945, L. paracasei LOCK 0920, and Yucca schidigera extracts are other practical ways to decrease OTA levels in broiler feed, as reported by the decrease of 5 ppm and 1 ppm OTA levels by 55% and 73%, respectively, during fermentation within 6 h with the same probiotics [130].
Similar biological methods involving bioactive agents have been developed to decrease PAT and/or Alternaria mycotoxins in target fruits and their derivative products. These methods are based on fermentation or adsorption by yeast (incl. Saccharomyces cerevisiae) and/or enzymatic degradation. These methods often involve lactic acid bacteria (LAB), Alicyclobacillus spp., and other target bacteria [48,54,55,83,131]. The same bioactive agents do not usually provoke unwanted changes in product quality, but further investigation is required to clarify some safety issues and the intimate mechanism involved in such detoxification (including the optimal parameters) in order to fully develop such methods for successful application in the juice or fruit industry.
Several mechanisms of bioactive destruction or removal of PAT have been described, including biosorption by bacteria or yeast [132,133], destruction by enzymes [88], and the destruction of its toxic potential [134,135]. On the other hand, the presence of PAT in the contaminated substrate can cause the production of PAT-destroying enzymes by yeast, which is resistant to PAT [88,106,136,137]. For example, the yeasts Saccharomyces cerevisiae and Gluconobacter oxydans can degrade PAT into Z-ascladiol and E-ascladiol [60,83], L. plantarum can degrade PAT to hydroascladiol [48], whereas Rhodosporidium paludigenum can degrade PAT to desoxypatulinic acid, which is a less toxic compound [88].
Enzymatic degradation of PAT is the most important mechanism of detoxification in juices prepared from pome fruit [89], as some enzymes with antioxidative properties are involved in the removal of reactive oxygen species [138]. In this regard, target enzymes such as peroxidase and polyphenol oxidase have been reported to decrease PAT content in fruits [118]. For example, polyphenol oxidase, which is extracted from apples, has been reported to strongly decrease PAT content in apple juice. Such enzymes, like peroxidase and/or glucose oxidase, were found to reduce Alternaria mycotoxins not only in fruits but also in tomatoes. For example, the extract from horseradish peroxidase was reported to reduce the level of Alternaria mycotoxin alternariol (AOH) in tomatoes [117], glucose oxidase produced by Aspergillus niger was reported to reduce the AOH content in apples, and CotA laccase produced by Bacillus licheniformis ZOM-1 was reported to destroy AFs, ZEA, or AOH [116].
Enzymatic degradation has also been applied to OTA, and some proteolytic enzymes, such as carboxypeptidase A, trypsin, and α-chymotrypsin, were found to be successful in OTA hydrolysis as early as 1969; however, carboxypeptidase A was reported to be more successful in OTA hydrolysis [111]. The main mechanism of OTA degradation includes hydrolysis of its amide bond via hydrolytic enzymes such as carboxypeptidase A, lipase A, protease A, and ochratoxinase [39,108].
Among the commercially purified enzymes, the crude enzyme Ancex is reported to be very powerful in OTA degradation when compared to other enzymes, such as Pancreatin, Protease A, or Prolyve PAC [109]. The crude metalloenzyme produced by Aspergillus niger was also reported to be very powerful in OTA hydrolyzation compared to carboxypeptidase A [115]. Purified recombinant ochratoxinase has been reported to be more effective in OTA hydrolysis than carboxypeptidase A at the target pH and temperature [139]. Other enzymes produced by Aspergillus tubingensis (M074 and M036) have also been reported to be very effective for OTA removal (>90% of OTA was removed at 25 °C and pH 5) [99].
A good example of industrial application is the commercial product Mycofix® PlusMTVINSIDE elaborated by Biomin GmbH (Austria), based on the good OTA detoxification potential of T. mycotoxinivorans (MTV, 115).
Obviously, a lot of microorganisms or fungi/yeast, having powerful OTA-adsorbing or degrading capabilities, in addition to the target enzymes cloned or produced by such fungi/yeast/microorganisms or by the pancreas of some animals, could receive or already have received great application prospects in the food/feed industry.
The high efficacy and absence of pollution in processed feeds, fruits, and derived products could explain the leading role of biodegradation as a promising new strategy for mycotoxin control. Nowadays, it is discovered that many microorganisms or fungi have the potential to destroy or decrease mycotoxin content in feeds/foods and their derived products. In this regard, further efforts are required to clarify the mechanisms responsible for the detoxification process and isolate the enzymes involved.

2.2. Antagonistic Microorganisms, Fungi, or Yeast with Fungicidal Properties Against Mycotoxin Contamination

A practical and safe biological method for preventing mycotoxin contamination of feeds/foods and their derived products is treatment with some microbial/fungal antagonists, which appears to be a powerful alternative to some conventional fungicides. The development of safe biological technologies to inhibit the growth of toxinogenic fungi is highly desirable. For example, Bacillus subtilis was found to prevent the growth of Fusarium fungi [34].
Atoxigenic Aspergillus flavus strains were reported to decrease AFs levels in treated feeds/foods and derived products [140] because they develop in the same ecological space/niche as mycotoxin-producing fungi and displace them. For example, spores of atoxigenic A. flavus strains inoculated on sorghum or barley could be a safe and practical technology for preventing feed contamination with AFs. Such inoculation can completely displace AF-producing strains and could be a safe and practical strategy for reducing the preharvest AFs content in crops [141].
Therefore, the use of naturally encountered atoxigenic Aspergillus strains for competitive exclusion of toxigenic strains appears to be a powerful method for controlling AFs content in foods/feeds. This strategy of using atoxigenic Aspergillus strains against toxigenic strains could be applied to control AFs production in the field, with a subsequent decrease in AFs contamination during storage.
This biocontrol approach against AFs contamination was first introduced in 1993 [142] and subsequently applied in many other countries worldwide [143]. However, such a strategy requires a predominance of atoxigenic strains above toxigenic ones in the field circumstances [144]. This could be achieved by applying the same atoxigenic strains, also known as biopesticides, in the field to ensure competition with toxigenic strains and the suppression of their multiplication, resulting in a decrease in AFs production [145] (Table 2) [34,56,90,131,135,140,141,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205].
A. flavus strain NRRL21882 and A. parasiticus strain NRRL21369 were also reported to be very effective biocontrol agents against AFs contamination in peanuts when applied under field conditions at preharvest time or at postharvest storage. Another atoxigenic strain, BN30, was found to be effective in preventing AFs contamination in maize in Africa [184]. In Australia, non-toxigenic strains have been reported to reduce AFs contamination in peanuts by up to 95% [182]. In China, approximately 30 non-toxigenic A. flavus strains were examined as biocontrol agents, and the AF051 strain was reported to be most effective in the control of AFs, with up to a 99% decrease in peanut fields [185].
A decrease in the AFs contamination of maize by up to 65–94% was achieved in a four-year study using atoxigenic CT3 and K49 strains [145]. Similarly, a potent decrease in AFs has been reported in groundnut fields using the atoxigenic AR100G, AR27, and AFCHG2 strains of A. flavus in Argentina [186]. Aspergillus niger strain FS10 has also been reported to decrease AFs production in the field [187,188].
Penicillium chrysogenum strain RP42C was also reported to suppress the growth of toxigenic Aspergillus strains [189].
Some yeast strains, such as Kluyveromyces spp., Debaryomyces hansenii strain BCS003, Candida maltose, Pichia anomala, Saccharomyces cerevisiae RC016, and Saccharomyces cerevisiae RC008, have been found to significantly decrease the growth of Aspergillus spp. and subsequent AFs production [147].
Trichoderma spp., T. viridae, T. harzianum, T. Auroviride, and T. longibrachiatum have been reported to be very effective against AFs production in the field at rates between 50% and 80% [147,190,206]. Trichoderma spp. were also found to decrease AFs contamination in sweet corn and groundnuts by 65% and 57%, respectively [157].
Some bacterial species, such as Lactobacilli, Streptomyces, Ralstonia, Stenotrophomonas, Pseudomonas, Burkholderia, and Bacillus have been reported to be effective against AFs contamination. Bacillus spp., such as B. subtilis, B. megaterium, B. mojavensis, B. amyloliquefaciens, B. mycoides, B. pumilus, B. cereus, and B. mojavensis were found to be effective biocontrol agents against AFs contamination [147,148,149,150,151]. Bacillus megaterium was reported to prevent nearly 100% of AFs production in a broth medium [148], whereas Bacillus subtilis was found to control the development of Aspergillus parasiticus (nearly 92%) and subsequent AFs production by up to 100% [149].
Pseudomonas chlororaphis strains isolated from maize have been reported to inhibit A. flavus development by nearly 100% [152]. Pseudomonas fluorescens was found to suppress the conidial germination of A. flavus by nearly 20% [178], in addition to inhibiting AFB1 production (> 99%) in peanut medium [177]. Pseudomonas protegens strain AS15, isolated from rice grains, was found to suppress up to 83% of AFs production, in addition to suppressing the development of A. flavus (up to 68%) [179].
Lactobacillus (LAB), such as L. delbrueckii, L. plantarum, L. reuteri, L. acidophilus, L. rhamnosus, L. paraplantarum, L. fermentum, L. Casei, and L. pentosus, have also been reported to be effective against AFs; however, L. plantarum was found to be the most effective against AFs production [173,174,175].
Lactobacillus plantarum B4496, Lactobacillus brevis 207, and Lactobacillus sanfranciscensis BB12 isolated from fermenting cocoa were found to have good in vitro antifungal activities against the three OTA-producing fungi, A. niger, A. Carbonarius, and A. ochraceus, with suppression capabilities ranging from 15% to 67% [176].
Streptomyces strains, such as S. anulatus, S. yanglinensis, S. roseolus, and S. alboflavus, were also found to be highly effective against aflatoxigenic fungi, such as Aspergillus flavus [153,154,155].
The bacterium Serratia marcescens strain JPP1, isolated from peanut shells, was found to suppress AFs production by nearly 98% and the subsequent growth of A. parasiticus by nearly 95% [180]. Nannocystis exedens was also found to significantly suppress the growth of A. flavus and A. parasiticus [156].
In vitro antifungal activities against OTA- and AFs-producing fungi were found in fermented cell-free supernatants of Paenibacillus chibensis CECT 375, Bacillus amyloliquefaciens CECT 493, and Pantoea agglomerans CECT 850, owing to high levels of acetic acid, lactic acid, phenyllactic acid, and benzoic acid [172].
Rhodotorula glutinis yeast strain LS11 was found to reduce the PAT content and destroy mycotoxins in vitro [90]. It has also been reported that the initial PAT content could be reduced by approximately 80% after 2 days of incubation with the antagonistic yeast Pichia ohmeri, and 15 days later, PAT was completely undetectable [191].
Incubation with Pichia caribbica yeast for 15 days has also been found to reduce PAT levels in apples [192]. A decrease in PAT levels was reported after inoculation with other biocontrol agents, such as Pantoea agglomerans CPA-1 and Candida sake CPA-2 [193], or some ascomycota yeast species, such as Candida guilliermondii P3 and Pichia ohmeri 158 [181]. The reduction in PAT levels was thought to be a result of fruit protection against infestation by the PAT-producing P. expansum strain and/or PAT absorption, but not metabolization [207].
Other antagonistic yeasts/microorganisms or their extracts, which can suppress fungal growth and production of PAT, have been reported mainly for apples and include some laboratory cultures, such as Torulaspora delbrueckii [195] and Candida membranifaciens [194], in combination with silicon. The decrease in PAT production by P. expansum, when co-incubated with antagonistic yeast was attributed to the growth inhibition of P. expansum and subsequent decrease in its mycotoxin production [137]. Some LAB strains and cell-free LAB supernatants were also found to suppress the growth of P. expansum and Aspergillus parasiticus by 58% and 73%, respectively, in a liquid medium after 48 h of incubation [135].
Other microorganisms, such as Bacillus subtilis and Pseudomonas fluorescens, have been shown to decrease PAT content in apples [171]. Potent control of the development of fungal strains P. expansum and Botrytis cinerea was also achieved by inoculation with some Pseudomonas syringae isolates after nearly a month of storage [131].
The reported inhibition by such bioactive agents could be attributed to competition for available space and/or nutrients, the synthesis of target bioactive antagonistic compounds, which inhibit spore germination and fungal growth, and/or direct predation by antagonist rivals [170,196].

Mechanisms of Protection, Factors Influencing Antifungal Activity and Industrial Applicability

The modes of inhibitory effects of the protectors include the following: (1) competition for nutrient and living space among antagonists, which grow rapidly and occupy ecological niche of pathogens and thus displacing them; (2) inhibition of fungal growth and reduction of target fungal infection and colonization; (3) inhibition of mycotoxin production. The inhibitory compounds are usually secondary metabolites and antimicrobial substances such as lipopeptides, protease antibiotics, bacteriocins, enzymes, and organic acids, such as aflastatin A or dioctatin A, etc., which suppress mycotoxin production [162,163,164].
The main mechanisms of inhibitory actions include the following: (1) destabilization or destroying cell wall structure; (2) affecting the activities of mitochondria, nuclei, or cellular membranes; (3) downregulation of expression of mycotoxin synthesis-related genes or a combination of several of the above-mentioned mechanisms [147,162,163,164].
The Bacillus spp. usually produced a wide range of antimicrobial compounds, grow rapidly, and are safe species; therefore, they have often been investigated as biological agents [147,148,149,150,151]. Bacterial antagonists were reported to be dominant (61%) compared with antagonistic fungi (27%) or yeast (12%), but currently, the introduction of non-toxigenic A. flavus into the field appears to be the most promising strategy for the prevention of preharvest AFs contamination [147], and A. flavus strain NRRL21882 is commercially available as a biopesticide Afla-guard® [183]. Currently, only non-toxigenic A. flavus strain NRRL21882 and NRRL18543 have been commercialized in terms of application in the field. The same biopesticide and biocontrol approach proved to be effective on peanuts [158], cottonseed [159], and corn [160]. The application of non-toxigenic A. parasiticus in the field was also found to reduce AFs contamination during storage time [161]. However, Trichoderma species also show a good potential to be commercialized in the future [157].
Usually, a strong relationship is observed between the inoculum rate and effectiveness of most biocontrol agents. Soil temperature also influences the effectiveness of biocontrol agents and should be above 20 °C in most cases. Therefore, late spring is the optimal time for the application of atoxigenic biocontrol agents. The first biocontrol agent (strain Aspergillus flavus AF36) against AFs contamination of cottonseed was registered in Arizona, USA, which was subsequently found to be effective against toxigenic A. flavus strains in corn, with a 70–90% decrease in AFs production in cotton and peanut reported in some field experiments when applying such atoxigenic Aspergillus strains [146].
Similarly, the inoculation of biomodulating microorganisms that are capable of suppressing P. expansum growth or destroying its metabolism could be a practical and safe technology for decreasing PAT content during the storage of some fruits. Postharvest decay induced by P. expansum can be effectively prevented using such a powerful and safe strategy for suppressing PAT contamination in stored fruits [90,191]. In this regard, dipping treatment of two apple cultivars in a Pseudomonas fluorescens cell suspension prior to dipping treatment in a P. expansum spore suspension was shown to inhibit fungal development on apples at postharvest time during commercial storage, which was reported to be comparable to that of commercial fungicides [170].
Mycotoxin production by fungi is usually influenced by temperature, water activity, pH values, nutritional source, among others. The antifungal activity of various biocontrol microorganisms, fungi, or yeast is also influenced by the same or similar factors and various environmental conditions. For example, the bioactivity of L. plantarum, which is one of the best protectors against AFs-producing strains, increases in low pH values, similar to some fungi or yeast species [165]. The best antagonistic activities of yeast strains Saccharomyces cerevisiae RC008 and RC016 are at pH value 4 [166]. However, the best pH value for each antagonistic fungus, microorganism, or yeast is species dependent.
Temperature and water activity are also of high importance for the antifungal efficiency of antagonists. For example, the yeast strain Debaryomyces hansenii can stimulate the AFs production of A. parasiticus at water activity of 0.99 but significantly reduce AFs production at water activity of 0.92 [167].
In regard to temperature, it is reported that the maximum activity of protein-degrading enzyme protease P6281, produced by the fungus T. harzianum, towards AFs is 40 °C [168], whereas some other antifungal species have different optimal ranges of antifungal activity and mycotoxin production.
Similarly, incubation time is also of significant importance, but the best inhibitory activity is usually anticipated after an incubation period of 3–4 days [169].
Obviously, water activity, pH value, incubation temperature, and nutritional source are of great importance for the growth of fungal species or yeasts and their antifungal activity. In this regard, profound practical work is required to identify the effective biocontrol agents before their application and commercialization.

3. Natural Herbal Supplements Having Powerful Protection Against Toxicity of Mycotoxins

3.1. Plants and Herbal Supplements with Powerful Protective Properties Against Target Mycotoxins

A powerful way to protect against the harmful toxic properties of mycotoxins on animal and human health is the addition of various natural mycotoxin-detoxifying supplements, such as herbs or plants that possess protective or antidote properties against mycotoxins [6,17,208,209,210,211,212,213,214,215,216]. For example, more than 7000 species of plants in India are currently used for medical purposes to cure various diseases or ailments [217] (Table 3) [9,10,11,14,15,17,208,209,210,211,212,213,215,216,218,219,220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,262,263,264,265,266,267,268,269,270,271,272,273,274,275].
Plant extracts or herbal supplements provided to the feedstuffs were found to protect against OTA-provoked decreases in weight gain among stock chicks [17,209,210] and prevent OTA-provoked decreases in egg production among laying poults [6]. Such protection against the toxic effects of OTA and improvement in OTA elimination from the organism was observed about 5% total water extract of dried leaves of artichoke (Cynara scolymus L) prepared as a steam infusion and administered to chicks at 5 mL/kg. b.w. via drinking water or forage [17,208,209,210]. The increase in the hepatobiliary route of OTA excretion via enhanced biliary secretion was attributed to the cynarine content in the artichoke extract [210], and the urinary route of OTA excretion was also improved by the increase in diuresis among artichoke-treated chicks [17,210]. Artichoke extract was also found to decrease OTA content in the kidneys and liver due to its increased elimination [209]. The edematous changes in OTA-treated chicks were also decreased due to vasoconstrictive and permeability-decreasing effects of the same herb [17,210], whereas hepatoprotective properties against OTA-provoked liver damage were attributed to the high content of flavonoids and cynarin in the artichoke extract. The improvement in diuresis by the same additive contributed to the decrease in serum glucose level, which was increased by OTA treatment [17,210].
Rosallsat, which is a commercial plant extract of bulbus Allii Sativi and seminum Rosae caninae, was also reported to have protective properties against OTA when taken at a dose of 0.6 mL/kg b.w. per day as a supplement to the chicken feedstuffs [210]. The bioactive compound “allicin” and the large quantity of some vitamins (e.g., E, A, F) in this plant extract were supposed to protect against OTA toxicity. Suppression of lipid peroxidation by Rosallsat was suggested to ameliorate the OTA-provoked increase in lipid peroxidation [276], which is responsible for cell membrane damage, subsequent influx of cellular Ca, and impairment of cellular metabolism and necrosis [277].
Roxazyme-G, a polyenzyme complement produced by the fungus “Trichoderma”, was found to be another powerful protector against OTA toxicity when administered at 200 ppm in chicken feedstuffs [209]. The improvement in energy metabolism by this supplement was responsible for the protective effect against OTA-induced disturbances in energy metabolism and the subsequent decrease in egg production. This assumption was supported by the decreased levels of serum glucose in chicks [209] and increased egg production in laying hens supplemented with the same polyenzyme complement [6]. The authors suggested that such natural feed additives could be used as a practical approach for the safe utilization of OTA-containing forages for chicks, thereby preventing the scrapping of such forages [209].
Ground sesame seeds have been reported to be another powerful natural protector against the OTA-provoked immunosuppression of humoral immune response and impairments in differential WBC count when administered at 80000 ppm to chicken feed. The same protection was attributed to the improved protein synthesis and enhanced division of immune cells, which are disturbed by OTA, and is due to the high level of phenylalanine in sesame seeds, which is a structural analog of OTA with antidote effects against this mycotoxin [209]. However, large-scale use of sesame seeds is impractical because of the high cost of such protection.
Protective effects of the herbal supplements Silybum marianum, Withania somnifera, and Centella asiatica, administered at feed levels of 1100, 4000, and 4600 ppm, respectively, were found against the immunosuppressive and toxic properties of OTA in broilers vaccinated against Newcastle disease and treated with 5 ppm OTA via the feeds [211]. The most powerful protective effects of W. somnifera and S. marianum were reported against OTA-provoked immunosuppression and damage to the kidneys and liver; however, the nephroprotective effect was stronger in poults supplemented with S. marianum, as evidenced by changes in biochemical and pathomorphological findings and relative organ weights. The use of these herbs has been suggested as a practical approach to combat the deleterious effects of OTA and to safely utilize OTA-contaminated forage. The mechanism of protection of these herbs was found to be different: S. marianum and W. somnifera were defined as good stimulators and protectors of the immune system; S. marianum was reported to be a good protector against OTA-induced damage in the liver and kidneys; and W. somnifera was reported to protect mainly against the hepatotoxic effects of OTA [211].
The hepatoprotective properties of S. marianum were also reported against liver damage induced by AFs, as evidenced by the decreased activities of the enzymes AST, alanine aminotransferase (ALT), and alkaline phosphatase (ALP) in the serum of AFs-compromised poults [219]. Such protection has been reported for Silymarin or Milk thistle (a seed extract of S. marianum) with regard to AFs-provoked liver damage in poults [220]. Body weight gain was significantly improved in poults supplemented with S. marianum or silymarin and exposed to AFs [211,219,220]. In addition to the improved gain in body weight, the feed conversion ratio was also improved in response to such treatment, and the same parameters were similar to those in poults treated with a toxin binder [219]. A similar increase in body weight gain was observed in rats protected with W. somnifera [235]. Supplementation of animal/chicken forages with either of the two herbs was found to significantly improve feed utilization.
Protection by milk thistle has also been reported against FB1-provoked liver or kidney damage in rats [278].
Potent protection by silymarin was also observed in AF-induced diabetic nephropathy [221] or cisplatin-induced kidney damage in rats [223] or against gentamicin-provoked damage in the kidneys of dogs [222].
The protective properties of silymarin against OTA-provoked damages to internal organs and the deleterious effects on biochemical indices, such as increased levels in uric acid, serum glucose, and enzyme activities of ALT and AST in OTA-compromised chicks, confirmed its powerful protection of the liver and kidneys [213].
A dose-dependent protective effect of silymarin against OTA-provoked immunosuppression was observed in another experiment. Silymarin and/or Vitamin E administered alone or together were reported to be powerful protectors of the immune system, but mainly at OTA exposure levels below 2 ppm [218].
A powerful liver-protective effect of S. marianum or silymarin was also observed against some other kinds of experimental damages in the liver of rats, as evidenced by the decrease in ALT, AST, ALP, lipid peroxidation, and tumor necrosis factor [225,226,227,228].
Silymarin and S. marianum are known to possess powerful antioxidative properties in addition to their strong immunomodulatory, membrane-stabilizing, hepatoprotective, and nephroprotective properties [211,213,219,220,227,228,231,279,280,281,282,283].
The protective properties of S. marianum, silymarin, or W. somnifera against mycotoxin-induced suppression of humoral or cell-mediated immune responses have been confirmed in other studies on the immunomodulatory properties of these herbs [231,233].
The suggested protective mechanism of S. marianum and silymarin was attributed to the suppression of lipid peroxidation and increased levels of endogenous antioxidants, which provided integrity to cellular membranes and prevented the leakage of some enzymes responsible for cellular death [227,229,230]. These antioxidant properties of silymarin or S. marianum are attributed to the powerful suppression of free radical production in the metabolism of toxic substances, increased levels of hepatic glutathione, and increased antioxidant defense in the liver [284]. The powerful protective effect of silymarin is due to some flavonoids, such as silybin, which possess powerful biological activities, including strong nephroprotective and hepatoprotective effects [279,280,285].
The herbal supplement W. somnifera has been reported to have similar immunoprotective and antioxidative effects [233], to suppress lipid peroxidation, to protect against liver damage [232], and to have potent neuroprotective properties [211,234]. This protection has been attributed to bioactive substances, such as saponins, steroidal lactones, and alkaloids [235].
It seems that the herbal supplements W. somnifera, silymarin, or S. marianum can be used as supplements to forage, with or without mycotoxin binders, to ensure the possible amelioration of the harmful effects of mycotoxin-contaminated feedstuffs in poultry farms [219,220]. Obviously, the same herbal supplements could provide a safe approach for the utilization of mycotoxin-containing feedstuffs, minimizing possible losses from reduced body weight of the birds, other possible losses from health issues, or discarding such mycotoxin-contaminated feed [1].
A protective effect on the gastric and intestinal mucosa and/or intima of vessels has been reported for the herbal additive C. asiatica [236,237], providing ameliorating effects against toxic damages caused by OTA or DON on the gastrointestinal mucosa and permeability of vessels [211]. This herb is recommended as a protective agent against oxidative stress and the deleterious effects of free radicals on mucosal integrity, thereby improving its barrier and defensive capabilities [236,237], which can be damaged by these mycotoxins [1]. The protective capability of the same herb against OTA-provoked immunosuppression and liver or kidney damages was slightly expressed [211,241].
A polyherbal feed supplement (“Growell”) was also found to be a good protector in some experimental cases of aflatoxicosis, ochratoxicosis, or combined mycotoxin intoxication in poults [262,263].
A protective effect of another herb, Tinospora cordifolia was found against OTA-provoked biochemical and oxidative changes in the spleen of mice [215,216]. Considering that many mycotoxins can induce oxidative stress [216,286] and worsen animal and human health, the antioxidant effects of herbs are highly appreciated. The protective capability of the T. cordifolia extract was attributed to its powerful antioxidant potential against oxidative stress and, therefore, it could protect against many mycotoxicoses [215,216]. The antioxidant properties of this herbal supplement were found to be related to its powerful radical scavenging potential against reactive nitrogen species (RNS) and reactive oxygen species (ROS) [287]. It is well known that ROS and RNS usually increase under the action of many mycotoxins, such as OTA [215,216]. The scavenging properties against ROS and RNS are related to the tannins and phenolic compounds in these extracts [288]. The same extract was also reported to ameliorate the genotoxicity of OTA, incl. 8-OHdG (8-hydroxy-2′-deoxyguanosine) genotoxic biomarker [215,216].
Glycyrrhiza glabra (Liquorice) is also a common herb often applied to various human ailments in the East and West [261] due to its potent hepatoprotective and antioxidative action [255,259,289] as well as its strong immunostimulating properties [212,258]. This protective effect is attributed to some biologically active compounds, including saponin glycyrrhizin, flavonoids, hispaglarbidin B, glabridin, licocoumarin, isoliquiritigenin, and some others [257], which are responsible for many natural protective properties of this herb, such as its antiviral, antibacterial, anti-inflammatory, hepatoprotective, cardiotonic, expectorant, antidiabetic, and antithrombotic effects [224,261]. That is why Gl. glabra could protect against the immunosuppressive, hepatotoxic, and pulmonary toxic effects of mycotoxins such as AFs, OTA, DON, and FUMs [212].
T. cordifolia has also been reported to have anti-inflammatory, immunostimulating, hepatoprotective, diuretic, antidiabetic, and anti-neoplastic properties, and to suppress lipid peroxidation [238,244,252,290], all of which are responsible for its protective effects against the nephrotoxic, hepatotoxic, immunosuppressive, and carcinogenic effects of some mycotoxins, improving mycotoxin elimination via the kidneys. This herb has been used to treat health ailments, such as dysentery and urinary diseases [290], which have often been reported in animals with mycotoxicoses.
Powerful protective properties against the suppressive effect of OTA on body weight gain and the associated pathomorphological and biochemical changes have been reported for the Gl. glabra and T. cordifolia herbs added to the feedstuffs for poults at 6600 and 4000 ppm, respectively [212]. The OTA-provoked decrease in relative organ weights, body weight, and antibody titer in chicks immunized against Newcastle disease was less expressed in poults supplemented with Gl. glabra or T. cordifolia in addition to OTA treatment, compared to poults treated with only OTA. The protective effect of both herbs on the immune system was supported by the higher relative weight of lymphoid organs of OTA-treated poults supplemented with the herbs as compared to poults treated with OTA only. The protection of both herbs against OTA-induced liver damages was also observed and better expressed in poults supplemented with Gl. Glabra, being associated with milder pathological damages and lower serum AST levels. T. cordifolia has also been reported to have good protective properties in the bone marrow and kidneys of poults, as supported by the lower serum levels of uric acid compared to poults without protection [212].
T. cordifolia [242] and Gl. glabra [258] extracts were also found to improve antibody production in vivo. T. cordifolia can improve phagocytic activity without significantly influencing humoral or cell-mediated immunity [245,291]. It is important to mention that T. cordifolia was found to influence production of cytokines and stimulate the immune system by stimulating differentiation of B cells and activation of T cells [239,243].
T. cordifolia extract was also found to inhibit α-glucosidase, which is probably responsible for its antidiabetic properties [253,254] and ability to decrease serum glucose levels [288]. Therefore, this herb was reported to decrease the levels of serum glucose in poults that ingested OTA via their diet and additionally supplemented with T. cordifolia [212], thus ameliorating OTA-provoked increases in serum glucose levels.
The powerful hepatoprotective potential of T. cordifolia has been reported against various experimental liver damages [248] induced by carbon tetrachloride [249,252], bile salts [245], and lead nitrate [250]. The same herb has been reported to suppress lipid peroxidation [240,246], ameliorating damage to internal organs due to OTA-induced increase in lipid peroxidation [212].
T. cordifolia was found to have protective effects against kidney and liver damages induced by AFs [247]. T. cordifolia was also reported to have protective effects on the gastrointestinal system [251], which could be attributed to the prevention of damages provoked by free radicals on the gastrointestinal mucosa [216], ameliorating the toxic effects of mycotoxins, such as DON or OTA [212] on the mucosa of the intestine.
It seems that both herbs T. cordifolia and Gl. glabra possess powerful antioxidative effects, as well as organ-protective and immunostimulating properties [246,256,257], and can be potent inhibitors of lipid peroxidation [260]. Therefore, both herbs could be potent protectors against the toxic effects of mycotoxins such as OTA, AFs, DON, or FUMs by decreasing lipid peroxidation and/or oxidative stress [216,292], liver and kidney damage [247], gastrointestinal damage [251], and immunosuppression [212].
The actual mechanism of protection of both herbs Gl. glabra and T. cordifolia in the previously mentioned experimental studies with chicks or rats could be partially explained by the suppression of lipid peroxidation and the increased levels of endogenous antioxidants that support the integrity of the cellular membrane and prevent possible leakage of target enzymes into the cytosol, which can lead to cellular death. On the other hand, the immunosuppressive effect of mycotoxins is often responsible for some neoplasms, because the important function of suppressed natural killer cells is to kill any neoplastic cells that are excluded from the physiological community [10,14,293]. Therefore, these herbs may also have anticarcinogenic properties. In addition, the same herbs were found to have a potent antibacterial or antiviral effect, thus simultaneously serving as powerful immune boosters [211] and possibly preventing secondary bacterial diseases induced by mycotoxin-provoked immunosuppression [18]. Moreover, together with the above-mentioned protective properties, these herbs have been found to protect against various kinds of toxic damage to the kidney, liver, and gastrointestinal system [216,224,248] and, therefore, could ameliorate the damage induced to the same organs by mycotoxins such as AFs, OTA, DON, or FUMs in animals or poultry [212].
A nephroprotective effect was also reported for oleanolic acid, which was found to ameliorate OTA-induced apoptotic damages and increase cell viability of epithelial cells from the proximal tubules of human kidneys (HK-2) [275]. The same natural compound is present in target medicinal plants and fruit skins.
Another bioactive compound possessing nephroprotective properties, which is present in some medicinal plants and cuticular waxes of some fruits, is ursolic acid. It was also reported to ameliorate mitochondria-mediated apoptosis in HK-2 cells induced by OTA treatment [273]. Pretreatment with 1 μM ursolic acid was also found to alleviate cell death and ROS production induced by OTA exposure in human embryonic kidney cells [274].
Turmeric powder, which is another natural product, was found to be a good alternative to mineral binders and has been reported to ameliorate AFB1-provoked toxic damage, such as increased lipid peroxidation in the livers of farm animals and poultry [265]. It was also found to increase the hepatic gene expression of target antioxidant enzymes (e.g., SOD2 and CAT) and decrease the contamination levels of AFB1 in the liver of broilers [265].
The methanolic extracts of M. oleifera, A. leiocarpus, I. asarifolia, B. refescens, and G. senegalensis, were also found to have potent antioxidative effects, which were attributed to the presence of flavonoids, alkaloids, and tannins. It has been reported that the DPPH free radical scavenging activities of methanolic extracts of M. oleifera and A. leiocarpus were the best among all examined extracts [264]. Desmodium ramosissimum methanolic extract has also been shown to have similar antioxidative properties and DPPH-free radical scavenging activity, and is widely used in traditional medicine [294].
Unfortunately, most reports on the antioxidative properties of plant extracts have not been studied in practice as possible protective agents against the deleterious effects of mycotoxins. It is worth mentioning that some methods of maize processing, such as treatment with lime water in the production of tortillas, can significantly reduce AFs content [36]. In addition, a synergistic interaction was observed in the destruction of AFB1 between lemon juice, citric acid, and heating/frying in pistachios contaminated with AFB1. Unfortunately, such processing can deteriorate some of the valuable taste qualities of the treated product [295].

Industrial Applicability and Limitations

By analyzing the available data in the literature, we can conclude that some herbs such as T. cordifolia, W. somnifera, Gl. glabra, silymarin, and S. marianum, or polyenzyme complements such as Roxazyme-G produced by the fungus “Trichoderma”, could be powerful protectors against mycotoxin toxicity, in addition to natural mycotoxin binders, and could ensure better utilization of mycotoxin-contaminated feedstuffs by improving the weight gain of mycotoxin-compromised commercial chicks/animals.
It seems that herbal or enzyme protections could be introduced in practice for large-scale use to ensure the safe utilization of such mycotoxin-contaminated feedstuffs [211,212]. The polarity of therapeutic compounds in herbs suggests the use of polar solvents for extraction [212].
The eventual economic loss resulting from the scrapping of mycotoxin-contaminated feedstuffs or the loss of body weight gain of animals/poults exposed to such feedstuffs could be avoided only by investing funds to purchase such herbal or enzyme products. In order to find suitable protectors for each mycotoxin, it is necessary to know in depth the specific mechanisms of its toxicity. Therefore, additional efforts are required to elaborate and implement such protection in large-scale applications.
However, it should be emphasized that there are some legislative restrictions on the use of food and feed additives in the EU. The restrictions for food additives include authorization and listing in the EU’s positive list, based on safety assessment and technological need. The Feed Additives Regulation (Regulation (EC) No. 1831/2003) of September 2003 establishes a common procedure for authorizing feed additives and lays down rules for their placing on the market, labeling, and use. In addition, EC Regulation No. 429/2008 of 25 April 2008 gives detailed rules for the implementation of EC Regulation No. 1831/2003 in regard to the preparation and presentation of applications, as well as the assessment and the authorization of feed additives.

3.2. Herbs and Plants Suppressing the Growth of Fungi and Production of Mycotoxins

Some bioactive compounds in herbs and plant extracts, such as flavonoids, polyphenols, silymarin, and carotenoids, have potent antifungal properties. The same compounds may suppress the growth of fungi such as Aspergillus flavus, preventing contamination of feedstuffs or food commodities with AFs [198,199,200,296,297] and, therefore, could be used in practice to prevent possible contamination with mycotoxins.
Plant extracts have also been found to suppress the growth of fungi that produce PAT and Alternaria mycotoxins. Some essential oils, such as clove and cinnamon oil, have been found to reduce PAT level in apples [201]. Garlic extract was found to be effective against Alternaria mycotoxins in tomatoes, whereas plant extracts of essential oils and/or monoterpenoids [203], as well as garlic extract and/or exposure to garlic vapor, strongly suppressed the fungal growth of Fusarium oxysporum and/or P. expansum in apples [205].
Natural extracts of orange peel and cistus were found to have good antifungal activity against the toxigenic Aspergillus carbonarius strain in a grape-based medium at concentrations of 10 and 20 mg/mL, whereas Eucalyptus extract was reported to reduce OTA production by up to 85% at a concentration of 10 mg/mL, with a slight influence on fungal growth [202].
Natural antioxidants have also been reported to be very effective in controlling postharvest fungi and suppressing PAT production [60], including fungal control and the production of mycotoxins such as AFs or OTA [204]. Other antioxidants such as vanillic acid have also been found to be useful in suppressing OTA production [197].

4. Some Natural Compounds or Vitamins Possessing Protective Effects Against Mycotoxicoses

Some energy boosters such as Roxazyme-G were reported to be effective against OTA-induced suppression of energy metabolism [209]. Some known suppressors of lipid peroxidation, such as Rosallsat [209,210], are also used as antidotes against OTA-provoked increases in lipid peroxidation, which is another important mechanism of OTA toxicity [276].
The protective properties of phenylalanine have also been reported against OTA-induced changes in blood biochemistry and pathology in rats. The number of OTA-induced neoplastic changes in rats supplemented with 20 ppm phenylalanine and exposed simultaneously to 10 ppm OTA was similar to that in rats exposed to two times lower OTA concentrations, which suggests a protective effect against the carcinogenic effect of OTA [14,15].
Protection of phenylalanine was also reported against OTA-induced teratogenic effects and malformations in mice supplemented with 20 ppm phenylalanine to the feeds [11], which confirmed its specific protective properties in this direction.
The reported protective properties of phenylalanine against OTA-provoked immunosuppression in humoral immune response were defined to be a result of increased protein synthesis, which is damaged by OTA, and to the consequent improvement of the division of immune cells, which is suppressed by OTA [209].
A slight protection of phenylalanine against OTA-provoked decrease in egg production was also reported in laying hens treated simultaneously with or without OTA and phenylalanine [6], suggesting a wide range of protective properties of the same antidote against the different toxic effects of OTA.
Ascorbic acid supplementation (300 ppm) in the diet of laying hens exposed to 3 ppm OTA was found to ameliorate egg production, including the number and weight of eggs [271,272], suggesting the protective properties of vitamins against the toxic effects of mycotoxins (Table 3).
Similar protective effects were reported for ascorbic acid and vitamin B, which have been found to facilitate PAT degradation [267]. Given that ascorbic acid and ascorbate are present naturally in many fruits, such as apples, and are additionally found to be capable to decrease PAT content in apple juice [268,269,270], their large-scale use at industrial levels is advisable. PAT degradation by ascorbic acid has also been reported to be more powerful in the presence of light and oxygen [269], which has no adverse effects on animal or human health and can be used easily.
Another natural protection was found for the combination of vinegar, sodium bicarbonate, and citric acid supplemented to apple juice, which has been reported to reduce PAT content [266,298].
A similar protection against OTA-induced immunotoxicity was also established for vitamin E supplementation in a dose-dependent manner in chicken feed, but this protection was only found to be applicable at low contamination levels of OTA below 2 ppm [218].
Some natural changes in the carbohydrate, protein, and fat content of the diet—such as low carbohydrate content or calorie restriction, high protein content, and low dietary fats—were also found to be partially beneficial against target mycotoxicoses such as AF toxicosis [267,299].
The toxic effects of mycotoxins can also be reduced by administering mycotoxin-contaminated forage to animals that are less sensitive to a particular mycotoxin, such as ruminants, which are less sensitive to OTA because of its hydrolysis in the rumen to the non-toxic substance ochratoxin α (OTα) [300].
Therefore, any kind of knowledge regarding mycotoxin metabolism or the routes of mycotoxin excretion and degradation is of particular significance for any kind of mycotoxin in any kind of animal in order to facilitate the finding of adequate possibility for reducing its toxicity.

Mechanisms of Protection by Knowing Target Mechanisms of Mycotoxin Toxicity

Generally, the toxic effects of mycotoxins can be reduced if the specific mechanisms of toxicity are known for each target mycotoxin. This way, it will be easier to find some antidotes or vitamins that could prevent the specific mechanisms of such toxic effects when given as supplements to the diet [5]. In this regard, when the mechanisms of OTA toxicity are clear (for example, OTA suppression of energy metabolism, suppression of protein synthesis, or increase in lipid peroxidation), some proper antidotes that activate energy metabolism and protein synthesis or suppress lipid peroxidation could be experimentally evaluated for possible protection against OTA. For example, knowing that OTA toxicity is partly due to its structural homology with phenylalanine, which is responsible for protein synthesis suppression due to competition for a specific t-RNA [301], it could be assumed that phenylalanine would be a possible protector against OTA toxicity. However, the protective properties of phenylalanine against OTA-induced toxicity have been studied mainly via in vitro experiments, but few studies have been conducted with laboratory animals or poultry, suggesting partial protective effects of phenylalanine against OTA [6,10,11,14,15,209]. Therefore, such gaps in existing strategies need to be filled by conducting more “in vivo” studies to prove the suitability of such methods for protection against mycotoxins.

5. Novelties and Limitations of Biocontrol Approach Against Mycotoxins

5.1. Novelties and Advantages of Biocontrol Approach Against Mycotoxins

The high efficacy and lack of contamination in processed feed/food is a major advantage of the biocontrol approach and could explain its leading role as a promising new strategy for mycotoxin control.
Natural feed supplements usually attract the attention of industrial feed producers because they propose a safer and more cost-effective strategy for reducing mycotoxin exposure than other methods for mycotoxin decontamination [39]. Such supplements are non-toxic to animals and poultry [5,35,36,37] and can be easily excreted from the body [38]. The prevention of economic loss due to the scrapping of mycotoxin-contaminated feedstuffs or the decreased body weight of animals/poults exposed to mycotoxin-contaminated feeds can be restricted only by investing funds to purchase target herbal, microbial, or enzyme products.
Biocontrol strategy, e.g., microorganisms, yeast, enzymes, and natural substances, against mycotoxins is estimated to be a very friendly control approach compared with physical and chemical methods, both of which can deteriorate the nutrient value of feedstuffs or food commodities. A biocontrol approach could be used to metabolize, destroy, or deactivate mycotoxins into less or non-toxic compounds. Therefore, the large-scale industrial use of the biocontrol approach is highly desirable. Natural feed additives, natural organic binders, and bioactive supplements can be used for the safe utilization of mycotoxin-contaminated grains, feedstuffs, or foods without any subsequent health problems for animals or humans [5,35,36].
Mycotoxin degradation using microorganisms/fungi/yeasts revealed a new path for food/feed safety. Microorganisms or fungi can also be used as biopesticides, e.g., commercially available biopesticide Afla-guard [183]. Such a biopesticide and biocontrol approach was proved to be effective on peanuts [158], cottonseed [159], and corn [160].
The microbial agents and mycotoxin degradation enzymes have great potential for industrial applications in food/feed as well as in the fermentation industry [84,128,129]. For example, carboxypeptidase that can degrade OTA has been cloned and used to detoxify OTA [67]. However, more efforts have to be undertaken to clarify the toxicity of the resulting degradation compounds and the mycotoxin detoxification mechanisms in each particular case.

5.2. Limitations of Findings

Unfortunately, biocontrol methods have some well-known limitations. For example, mycotoxin biodegradation could be an effective approach, but it depends on multiple factors such as pH values, temperature, water activity, and nutritional source, which are of high importance for the antifungal efficiency of antagonists. Extensive studies and practical work are required to establish the optimal conditions for application of each biocontrol strain (fungi, yeasts or microorganisms) before its further application and commercialization
On the other hand, mechanisms involved in a mycotoxin’s biological control remain unclear. Much research has focused on the ability of microorganisms/fungi/yeasts to detoxify mycotoxins, but a better understanding of the enzymes involved and their underlying mechanisms is still needed. Therefore, further efforts are required to clarify the mechanisms responsible for the detoxification process and isolate the enzymes involved. Furthermore, the detoxification mechanism is important to be clarified in each particular case to prevent the simultaneous synthesis of other toxic metabolites during mycotoxin detoxification. In this regard, knowing the degraded compound’s toxicity is of particular importance because it can be either less or more toxic than the parent toxins. Methods for extracting enzymes from microorganisms/yeasts/fungi also need to be clarified and applied for large-scale use.
The elaboration of appropriate protectors for each mycotoxin requires in-depth knowledge of the specific mechanisms of its toxicity. In this regard, additional efforts are needed to discover and implement such protection in large-scale industrial applications.
Herbal and plant protection against deleterious effects of mycotoxins is always partial and cannot completely prevent their toxic effect on animals and birds. The legislative restrictions on the use of food and feed additives in the EU, which are based on safety assessment and technological need, should also be taken into account at the time of industrial application of each natural feed additive, e.g herb or plant.

6. Concluding Remarks and Future Perspectives

Biological methods of mycotoxin detoxification can ensure better food safety and preserve the flavor, organoleptic properties, and nutritional quality of treated feedstuffs and food commodities as compared to traditional chemical or physical methods. Moreover, such methods are environmentally friendly, easily available, and cost-effective compared with chemical or physical detoxification methods. Therefore, various adsorbents, clay binders, fungicides, microorganisms, herbal or plant additives, and enzymes are considered more desirable methods for mycotoxin decontamination and could be used as more practical feed additives for this purpose. However, further research is required to reveal their real potential compared with other methods for mycotoxin decontamination. Considering that clay binders are poorly efficient against most mycotoxins, except PAT and AFs, natural organic binders are highly recommended for the same purpose because of their good efficiency against multi-mycotoxin contamination of feedstuffs and their good biodegradability, which prevents possible environmental pollution.
The use of microbial antagonists was found to be a good alternative against conventional fungicides, and “detoxification by biotransformation” is considered a valuable new strategy for controlling mycotoxin contamination because of its high efficiency and lack of pollution. Many biological supplements provided as feed additives can promote mycotoxin degradation or biotransformation by target microorganisms, enzymes, yeast culture extracts, or natural antioxidants, which are less toxic or non-toxic and can be readily excreted or even utilized by animals/poultry. Some natural antioxidants used as feed additives have been proven to be very effective in postharvest fungal control and PAT inhibition, as well as in fungal control and/or inhibition of AFs and OTA. Such additives generally receive considerable attention from commercial feed enterprises because they provide a safe strategy to prevent mycotoxin exposure and reduce the bioavailability of mycotoxins. Considering that many mycotoxins co-exist in food commodities and feedstuffs, finding highly efficient strains that biodegrade or adsorb a large number of mycotoxins simultaneously should be a trend in future investigations.
Some herbs or herbal extracts, such as Tinospora cordifolia, Glycyrrhiza glabra, Silybum marianum, silymarin, Withania somnifera, etc., or target plants such as turmeric powder, or polyenzyme complements such as Roxazyme-G, could also be used in real-life practice together with target mycotoxin-binding agents to minimize the harmful effects of mycotoxin exposure through feed/food and to ensure better utilization of feedstuffs, greater body weight gain, and increased egg production in commercial animals or chickens. This approach could reduce economic losses from decreased animal production or the eventual condemnation of mycotoxin-contaminated fodder, as little expense would be incurred when purchasing the same herbs or herbal extracts. However, further efforts should be undertaken for their practical application in animal and chicken industries.
On the other hand, natural compounds in plant extracts or volatiles, and phenolic compounds such as isothiocyanates, which are naturally present in plants or apples, are found to be highly efficient in the control of fungal growth in fruits, and their application is completely safe. Some biologically active substances in plant extracts may also act as antifungal agents, such as flavonoids, silymarin, carotenoids, and polyphenols, inhibiting the growth of some fungi, such as Aspergillus flavus, and preventing AFs contamination of feed/food. Therefore, they serve as a practical way to prevent mycotoxin contamination of feed. In this regard, any piece of information about the metabolism and mechanisms of detoxification or the removal of any particular mycotoxin in each animal species or humans is essential to ensure the safe use of mycotoxin-contaminated fodder or food commodities without increasing the potential hazards and health issues. Additional research efforts should be undertaken to clarify the actual mechanisms of detoxification or degradation of mycotoxins, and to isolate the enzymes involved in such degradation.

Funding

Part of the quoted research investigations in this review paper were partially supported through travel or publication facilities (payment of APC) by the Faculty of Veterinary Medicine of Trakia University in Bulgaria, the European Community via the previous Marie Curie International Research Staff Exchange Scheme under the 7th Framework (PIRSES-GA-2012-316067—HERBAL PROTECTION), the Marie Curie Outgoing International Fellowship (MOIF-CT-2005-018674) in South Africa, and the Department of Science and Technology in South Africa.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Stoev, S.D. Foodborne Diseases due to Underestimated Hazard of Joint Mycotoxin Exposure at Low Levels and Possible Risk Assessment. Toxins 2023, 15, 464. [Google Scholar] [CrossRef] [PubMed]
  2. Stoev, S.D. Foodborne mycotoxicoses, risk assessment and underestimated hazard of masked mycotoxins and joint mycotoxin effects or interaction. Environ. Toxicol. Pharmacol. 2015, 9, 794–809. [Google Scholar] [CrossRef] [PubMed]
  3. Pereira, C.S.; Cunha, S.C.; Fernandes, J.O. Prevalent mycotoxins in animal feed: Occurrence and analytical methods. Toxins 2019, 11, 290. [Google Scholar] [CrossRef]
  4. Vlachou, M.; Pexara, A.; Solomakos, N.; Govaris, A. Ochratoxin A in Slaughtered Pigs and Pork Products. Toxins 2022, 14, 67. [Google Scholar] [CrossRef]
  5. Stoev, S.D. Food safety and increasing hazard of mycotoxin occurrence in foods and feeds. Crit. Rev. Food Sci. 2013, 53, 887–901. [Google Scholar] [CrossRef] [PubMed]
  6. Stoev, S.D. Studies on some feed additives and materials giving partial protection against the suppressive effect of ochratoxin A on egg production of laying hens. Res. Vet. Sci. 2010, 88, 486–491. [Google Scholar] [CrossRef]
  7. Gashaw, M. Review on Mycotoxins in Feeds: Implications to Livestock and human health. E3 J. Agric. Res. Dev. 2015, 5, 137–144. [Google Scholar]
  8. Hussain, F.; Usman, F.; Alajmi, R.A.; Bashir, M.A. Application of Biocontrol Agents and Plants Extract Against Fungal Phytopathogens of Vegetable Crops. Pol. J. Environ. Study 2024, 33, 3209–3216. [Google Scholar] [CrossRef]
  9. Chaudhary, R.; Nawaz, A.; Khattak, Z.; Butt, M.A.; Fouillaud, M.; Dufossé, L.; Munir, M.; Haq, I.; Mukhtar, H. Microbial bio-control agents: A comprehensive analysis on sustainable pest management in agriculture. J. Agric. Food Res. 2024, 18, 101421. [Google Scholar] [CrossRef]
  10. Stoev, S.D. Studies on carcinogenic and toxic effects of ochratoxin A in chicks Special issue “Ochratoxins”. Toxins 2010, 2, 649–664. [Google Scholar] [CrossRef]
  11. Stoev, S.D. Studies on teratogenic effect of ochratoxin A given via mouldy diet in mice in various sensitive periods of the pregnancy and the putative protection of phenylalanine. Toxicon 2022, 210, 32–38. [Google Scholar] [CrossRef] [PubMed]
  12. Kan, C.A.; Meijer, G.A.L. The risk of contamination of food with toxic substances present in animal feed. Anim. Feed Sci. Technol. 2007, 133, 84–108. [Google Scholar] [CrossRef]
  13. Pfohl-Leszkowicz, A.; Manderville, R.A. An Update on Direct Genotoxicity as a Molecular Mechanism of Ochratoxin A Carcinogenicity. Chem. Res. Toxicol. 2012, 25, 252–262. [Google Scholar] [CrossRef]
  14. Stoev, S.D. Follow up long term preliminary studies on carcinogenic and toxic effects of ochratoxin A in rats and the putative protection of phenylalanine. Toxicon 2021, 190, 41–49. [Google Scholar] [CrossRef] [PubMed]
  15. Stoev, S.D. New Evidences about the Carcinogenic Effects of Ochratoxin A and Possible Prevention by Target Feed Additives. Toxins 2022, 14, 380. [Google Scholar] [CrossRef] [PubMed]
  16. Pfohl-Leszkowicz, A.; Manderville, R.A. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51, 61–99. [Google Scholar] [CrossRef]
  17. Stoev, S.D.; Anguelov, G.; Ivanov, I.; Pavlov, D. Influence of ochratoxin A and an extract of artichoke on the vaccinal immunity and health in broiler chicks. Exp. Toxicol. Pathol. 2000, 52, 43–55. [Google Scholar] [CrossRef]
  18. Stoev, S.D.; Goundasheva, D.; Mirtcheva, T.; Mantle, P.G. Susceptibility to secondary bacterial infections in growing pigs as an early response in ochratoxicosis. Exp. Toxicol. Pathol. 2000, 52, 287–296. [Google Scholar] [CrossRef]
  19. Makhuvele, R.; Naidu, K.; Gbashi, S.; Thipe, V.C.; Adebo, O.A.; Njobeh, N.B. The use of plant extracts and their phytochemicals for control of toxigenic fungi and mycotoxins. Heliyon 2020, 6, e05291. [Google Scholar] [CrossRef]
  20. Quesada-Vázquez, S.; Codina Moreno, R.; Della Badia, A.; Castro, O.; Riahi, I. Promising Phytogenic Feed Additives Used as Anti-Mycotoxin Solutions in Animal Nutrition. Toxins 2024, 16, 434. [Google Scholar] [CrossRef]
  21. Randa Zeidan, R.; Ul-Hassan, Z.; Al-Thani, R.; Migheli, M.; Jaoua, S. In-Vitro Application of a Qatari Burkholderia cepacia strain (QBC03) in the Biocontrol of Mycotoxigenic Fungi and in the Reduction of Ochratoxin A biosynthesis by Aspergillus carbonarius. Toxins 2019, 11, 700. [Google Scholar] [CrossRef] [PubMed]
  22. Alvina Hanif, A.; Zhang, F.; Li, P.; Li, C.; Xu, Y.; Zubair, M.; Zhang, M.; Jia, D.; Zhao, X.; Liang, J.; et al. Fengycin Produced by Bacillus amyloliquefaciens FZB42 Inhibits Fusarium graminearum Growth and Mycotoxins Biosynthesis. Toxins 2019, 11, 295. [Google Scholar] [CrossRef] [PubMed]
  23. Kawtharani, H.; Snini, S.P.; Heang, S.; Bouajila, J.; Taillandier, P.; Mathieu, F.; Beaufort, S. Phenyllactic Acid Produced by Geotrichum candidum Reduces Fusarium sporotrichioides and F. langsethiae Growth and T-2 Toxin Concentration. Toxins 2020, 12, 209. [Google Scholar] [CrossRef]
  24. Gomomo, Z.; Fanadzo, M.; Mewa-Ngongang, M.; Hoff, J.; Van der Rijst, M.; Okudoh, V.; Kriel, J.; du Plessis, H.W. Control of Mould Spoilage on Apples Using Yeasts as Biological Control Agents. Pol. J. Food Nutr. Sci. 2022, 72, 119–128. [Google Scholar] [CrossRef]
  25. Smith, M.-C.; Madec, S.; Coton, E.; Hymery, N. Natural Co-Occurrence of Mycotoxins in Foods and Feeds and Their in vitro Combined Toxicological Effects. Toxins 2016, 8, 94. [Google Scholar] [CrossRef]
  26. Marc, R.A. Implications of Mycotoxins in Food Safety. In Mycotoxins and Food Safety—Recent Advances; IntechOpen: London, UK, 2022; Chapter 1; pp. 1–146. Available online: https://www.intechopen.com/books/11023 (accessed on 5 February 2024).
  27. CAST (Council for Agricultural Science and Technology). Mycotoxins: Economic and Health Risk; Task Force Report 116; CAST: Ames, IA, USA, 1989; pp. 1–91. [Google Scholar]
  28. Scott, P.M. Industrial and farm detoxification processes for mycotoxins. Rev. Med. Vet. 1998, 149, 543–548. [Google Scholar]
  29. Peraica, M.; Domijan, A.-M.; Jurjevic, Z.; Cvjetkovic, B. Prevention of Exposure to Mycotoxins from Food and Feed. Arch. Ind. Hyg. Toxicol. 2002, 53, 229–237. [Google Scholar]
  30. Kabak, B.; Dobson, A.D.W.; Var, I. Strategies to prevent mycotoxin contamination of food and animal feed: A review. Crit. Rev. Food Sci. Nutr. 2007, 46, 593–619. [Google Scholar] [CrossRef]
  31. Kubena, L.F.; Harvey, R.B.; Bailey, R.H.; Buckley, S.A.; Rottinghaus, G.E. Effects of a hydrated sodium calcium aluminosilicate (T-BindTM) on mycotoxicosis in young broiler chickens. Poult. Sci. 1998, 77, 1502–1509. [Google Scholar] [CrossRef]
  32. Di Gregorio, M.C.; Neeff, D.V.; Jager, A.V.; Corassin, C.H.; Carao, A.P.; Albuquerque, R.D.; de Azevedo, A.C.; Oliveira, C.A.F. Mineral adsorbents for prevention of mycotoxins in animal feeds. Toxin Rev. 2014, 33, 125–135. [Google Scholar] [CrossRef]
  33. Phillips, M.; Zhang, K. Mycotoxins and food safety-prevention and control: Expectation and reality. J. AOAC Int. 2019, 102, 1641. [Google Scholar] [CrossRef]
  34. Jouany, J.P. Methods for preventing, decontaminating and minimizing the toxicity of mycotoxins in feeds. Anim. Feed Sci. Technol. 2007, 137, 342–362. [Google Scholar] [CrossRef]
  35. Stoev, S.D. Natural feed additives and bioactive supplements versus chemical additives as a safe and practical approach to combat foodborne mycotoxicosis. Front. Nutr. 2024, 11, 1335779. [Google Scholar] [CrossRef]
  36. Stoev, S.D. Food security, underestimated hazard of joint mycotoxin exposure and management of the risk of mycotoxin contamination. Food Control 2024, 159, 110235. [Google Scholar] [CrossRef]
  37. Ofori-Attah, E.; Hashimoto, M.; Oki, M.; Kadowaki, D. Therapeutic Effect of Natural Products and Dietary Supplements on Aflatoxin-Induced Nephropathy. Int. J. Mol. Sci. 2024, 25, 2849. [Google Scholar] [CrossRef]
  38. Ji, C.; Fan, Y.; Zhao, L. Review on biological degradation of mycotoxins. Anim. Nutr. 2016, 2, 127–133. [Google Scholar] [CrossRef]
  39. Chen, W.; Li, C.; Zhang, B.; Zhou, Z.; Shen, Y.; Liao, X.; Yang, J.; Wang, Y.; Li, X.; Li, Y.; et al. Advances in Biodetoxification of Ochratoxin A—A Review of the Past Five Decades. Front. Microbiol. 2018, 9, 1386. [Google Scholar] [CrossRef]
  40. Guerre, P. Mycotoxin and gut microbiota interactions. Toxins 2020, 12, 769. [Google Scholar] [CrossRef]
  41. Yao, Y.; Long, M. The biological detoxification of deoxynivalenol: A review. Food Chem. Toxicol. 2020, 145, 111649. [Google Scholar] [CrossRef]
  42. Li, P.; Su, R.; Yin, R.; Lai, D.; Wang, M.; Liu, Y.; Zhou, L. Detoxification of Mycotoxins through Biotransformation. Toxins 2020, 12, 121. [Google Scholar] [CrossRef]
  43. Liu, L.; Xie, M.; Wei, D. Biological Detoxification of Mycotoxins: Current Status and Future Advances. Int. J. Mol. Sci. 2022, 23, 1064. [Google Scholar]
  44. Scudamore, K.A.; Banks, J.N. The fate of mycotoxins during cereal processing. In Meeting the Mycotoxin Menace, Proceedings of the 2nd World Mycotoxin Forum, Nordwijk, The Netherlands, 17–18 February 2003; Barug, D., van Egmond, H., López-García, R., van Osenbruggen, T., Visconti, A., Eds.; Wageningen Academic Publishers: Wageningen, The Netherlands, 2004; pp. 165–181. [Google Scholar]
  45. Nobre, C.; González, A.; Losoya, C.; Teixeira, J.; Belmares, R.; Abrunhosa, L. Detoxification of ochratoxin A and zearalenone by Pleurotus ostreatus during in vitro gastrointestinal digestion. Food Chem. 2022, 384, 132525. [Google Scholar]
  46. Bovo, F.; Franco, L.T.; Rosim, R.E.; Oliveira, C.A. Ability of a Lactobacillus rhamnosus strain cultured in milk whey based medium to bind aflatoxin B1. Food Sci. Technol. 2014, 34, 566–570. [Google Scholar] [CrossRef]
  47. Afshar, P.; Shokrzadeh, M.; Raeisi, S.N.; Ghorbani-HasanSaraei, A.; Nasiraii, L.R. Aflatoxins biodetoxification strategies based on probiotic bacteria. Toxicon 2020, 178, 50–58. [Google Scholar] [CrossRef]
  48. Hawar, S.; Vevers, W.; Karieb, S.; Ali, B.K.; Billington, R.; Beal, J. Biotransformation of patulin to hydroascladiol by Lactobacillus plantarum. Food Control 2013, 34, 502–508. [Google Scholar]
  49. Fuchs, S.; Sontag, G.; Stidl, R.; Ehrlich, V.; Kundi, M.; Knasmüeller, S. Detoxification of patulin and Ochratoxin A, two abundant mycotoxins, by lactic acid bacteria. Food Chem. Toxicol. 2008, 46, 1398–1407. [Google Scholar]
  50. Piotrowska, M. The Adsorption of Ochratoxin A by Lactobacillus Species. Toxins 2014, 6, 2826. [Google Scholar] [CrossRef]
  51. Piotrowska, M.; Zakowska, Z. The biodegradation of Ochratoxin A in food products by lactic acid bacteria and baker’s yeast. Food Biotechnol. 2000, 17, 307–310. [Google Scholar]
  52. Del Prete, V.; Rodriguez, H.; Carrascosa, A.V.; de las Rivas, B.; Garcia-Moruno, E.; Muñoz, R. In vitro removal of Ochratoxin A by wine lactic acid bacteria. J. Food Prot. 2007, 70, 2155–2160. [Google Scholar]
  53. Luz, C.; Ferrer, J.; Mañes, J.; Meca, G. Toxicity reduction of Ochratoxin A by lactic acid bacteria. Food Chem. Toxicol. 2018, 112, 60–66. [Google Scholar] [CrossRef]
  54. Hatab, S.; Yue, T.; Mohamad, O. Reduction of patulin in aqueous solution by lactic acid bacteria. J. Food Sci. 2012, 77, M238–M241. [Google Scholar] [CrossRef]
  55. Yuan, Y.; Wang, X.; Hatab, S.; Wang, Z.; Wang, Y.; Luo, Y.; Yue, T. Patulin reduction in apple juice by inactivated Alicyclobacillus spp. Lett. Appl. Microbiol. 2014, 59, 604–609. [Google Scholar]
  56. Khoury, R.E.; Mathieu, F.; Atoui, A.; Kawtharani, H.; Khoury, A.E.; Afif, C.; Maroun, R.G.; El Khoury, A. Ability of soil isolated actinobacterial strains to prevent, bind and biodegrade Ochratoxin A. Toxins 2017, 9, 222. [Google Scholar] [CrossRef]
  57. Bhatnagar, D.; Lillehoj, E.B.; Bennet, J.W. Biological detoxification of mycotoxins. In Mycotoxin and Animal Feeds; Smith, J.E., Henderson, R.S., Eds.; CRC Press: Boston, MA, USA, 1991; pp. 816–826. [Google Scholar]
  58. Taheur, F.B.; Fedhila, K.; Chaieb, K.; Kouidhi, B.; Bakhrouf, A.; Abrunhosa, L. Adsorption of aflatoxin B1, zearalenone and Ochratoxin A by microorganisms isolated from Kefir grains. Int. J. Food Microbiol. 2017, 251, 1–7. [Google Scholar] [CrossRef]
  59. Mateo, E.M.; Medina, Á.; Valle-Algarra, F.M.; Mateo, F.; Pardo, I.; Jiménez, M. Ochratoxin A removal in synthetic media by living and heat-inactivated cells of Oenococcus oeni isolated from wines. Food Control 2010, 21, 23–28. [Google Scholar] [CrossRef]
  60. Ricelli, A.; Baruzzi, F.; Solfrizzo, M.; Morea, M.; Fanizzi, F. Biotransformation of patulin by Gluconobacter oxydans. Appl. Environ. Microbiol. 2007, 73, 785–792. [Google Scholar] [CrossRef]
  61. Binder, J.; Schatzmayr, G.; Heidler, D.; Ellend, N.; Braun, R.; Binder, E.M. Microbial inactivation of trichothecenes—Development of a feed additive. In Proceedings of the 5th International Feed Production Conference, Piacenza, Italy, 15–16 June 1998; pp. 71–87. [Google Scholar]
  62. Shi, L.; Liang, Z.; Xu, S.; Zheng, H.; Huang, K. Adsorption and degradation of Ochratoxin A by Bacillus licheniformis Sl-1. J. Agric. Biotechnol. 2013, 21, 1420–1425. [Google Scholar]
  63. Petchkongkaew, A.; Taillandier, P.; Gasaluck, P.; Lebrihi, A. Isolation of Bacillus spp. from Thai fermented soybean (Thua-nao): Screening for aflatoxin B1 and Ochratoxin A detoxification. J. Appl. Microbiol. 2008, 104, 1495–1502. [Google Scholar]
  64. Abrunhosa, L.; Inês, A.; Rodrigues, A.I.; Guimarães, A.; Pereira, V.L.; Parpot, P.; Mendes-Faia, A.; Venâncio, A. Biodegradation of Ochratoxin A by Pediococcus parvulus isolated from Douro wines. Int. J. Food Microbiol. 2014, 188, 45–52. [Google Scholar] [CrossRef]
  65. De Bellis, P.; Tristezza, M.; Haidukowski, M.; Fanelli, F.; Sisto, A.; Mulè, G.; Grieco, F. Biodegradation of Ochratoxin A by bacterial strains isolated from vineyard soils. Toxins 2015, 7, 5079–5093. [Google Scholar] [CrossRef]
  66. Hwang, C.-A.; Draughon, F.A. Degradation of Ochratoxin A by Acinetobacter calcoaceticus. J. Food Prot. 1994, 57, 410–414. [Google Scholar] [CrossRef] [PubMed]
  67. Chang, X.; Wu, Z.; Wu, S.; Dai, Y.; Sun, C. Degradation of Ochratoxin A by Bacillus amyloliquefaciens ASAG1. Food Addit. Contam. A 2015, 32, 564–571. [Google Scholar] [CrossRef]
  68. Rodriguez, H.; Reveron, I.; Doria, F.; Costantini, A.; De Las Rivas, B.; Munoz, R.; Garcia-Moruno, E. Degradation of Ochratoxin A by Brevibacterium species. J. Agric. Food Chem. 2011, 59, 10755–10760. [Google Scholar] [CrossRef]
  69. Shi, L.; Liang, Z.; Li, J.; Hao, J.; Xu, Y.; Huang, K.; Tian, J.; He, X.; Xu, W. Ochratoxin A biocontrol and biodegradation by Bacillus subtilis CW 14. J. Sci. Food Agric. 2014, 94, 1879–1885. [Google Scholar] [CrossRef]
  70. Schatzmayr, G.; Zehner, F.; Täubel, M.; Schatzmayr, D.; Klimitsch, A.; Loibner, A.P.; Binder, E.M. Microbiologicals for deactivating mycotoxins. Mol. Nutr. Food Res. 2006, 50, 543–551. [Google Scholar] [CrossRef] [PubMed]
  71. Upadhaya, S.D.; Song, J.Y.; Park, M.A.; Seo, J.K.; Yang, L.; Lee, C.H.; Cho, K.J.; Ha, J.K. Isolation, screening and identification of swine gut microbiota with Ochratoxin A biodegradation ability. Asian Austral. J. Anim. 2012, 25, 114–121. [Google Scholar] [CrossRef]
  72. Ferenczi, S.; Cserháti, M.; Krifaton, C.; Szoboszlay, S.; Kukolya, J.; Szoke, Z.; Kőszegi, B.; Albert, M.; Barna, T.; Mézes, M.; et al. A new Ochratoxin A biodegradation strategy using Cupriavidus basilensis Or16 Strain. PLoS ONE 2014, 9, e109817. [Google Scholar] [CrossRef] [PubMed]
  73. Molnar, O.; Schatzmayr, G.; Fuchs, E.; Prillinger, H. Trichosporon mycotoxinivorans sp. nov., a new yeast species useful in biological detoxification of various mycotoxins. Syst. Appl. Microbiol. 2004, 27, 661–671. [Google Scholar] [CrossRef]
  74. Vekiru, E.; Hametner, C.; Mitterbauer, R.; Rechthaler, J.; Adam, G.; Schatzmayr, G.; Krska, R.; Schuhmacher, R. Cleavage of zearalenone by Trichosporon mycotoxinivorans to a novel nonestrogenic metabolite. Appl. Environ. Microbiol. 2010, 76, 2353–2359. [Google Scholar] [CrossRef]
  75. Varga, J.; Kocinfe, S.; Peteri, Z.; Vagvolgyi, C.; Toth, B. Chemical, physical and biological approaches to prevent ochratoxin induced toxicoses in humans and animals. Toxins 2010, 2, 1718–1750. [Google Scholar] [CrossRef]
  76. Politis, I.; Fegeros, K.; Nitsch, S.; Schatzmayr, G.; Kantas, D. Use of Trichosporon mycotoxinivoransto to suppress the effects of ochratoxicosis on the immune system of broiler chicks. Br. Poult. Sci. 2005, 46, 58–65. [Google Scholar] [CrossRef]
  77. Hartinger, D.; Moll, W.D. Fumonisin elimination and prospects for detoxification by enzymatic transformation. World Mycotoxin J. 2011, 4, 271–283. [Google Scholar] [CrossRef]
  78. Patharajan, S.; Reddy, K.R.N.; Karthikeyan, V.; Spadaro, D.; Lore, A.; Gullino, M.L.; Garibaldi, A. Potential of yeast antagonists on in vitro biodegradation of Ochratoxin A. Food Control 2011, 22, 290–296. [Google Scholar] [CrossRef]
  79. Péteri, Z.; Téren, J.; Vágvölgyi, C.; Varga, J. Ochratoxin degradation and adsorption caused by astaxanthin-producing yeasts. Food Microbiol. 2007, 24, 205–210. [Google Scholar] [CrossRef]
  80. Yang, Q.; Wang, J.; Zhang, H.; Li, C.; Zhang, X. Ochratoxin A is degraded by Yarrowia lipolytica and generates non-toxic degradation products. World Mycotoxin J. 2016, 9, 269–278. [Google Scholar] [CrossRef]
  81. Schatzmayr, G.; Heidler, D.; Fuchs, E.; Nitsch, S.; Mohnl, M.; Taubel, M.; Loibner, A.P.; Braun, R.; Binder, E.M. Investigation of different yeast strains for the detoxification of Ochratoxin A. Mycotoxin Res. 2003, 19, 124–128. [Google Scholar] [CrossRef]
  82. Chlebicz, A.; Śliżewska, K. In vitro detoxification of aflatoxin B1, deoxynivalenol, fumonisins, T-2 toxin and zearalenone by probiotic bacteria from genus Lactobacillus and Saccharomyces cerevisiae yeast. Probiotics Antimicrob. 2020, 12, 289–301. [Google Scholar] [CrossRef]
  83. Moss, M.O.; Long, M.T. Fate of patulin in the presence of the yeast Saccharomyces cerevisiae. Food Addit. Contam. 2002, 19, 387–399. [Google Scholar] [CrossRef]
  84. Farbo, M.G.; Urgeghe, P.P.; Fiori, S.; Marceddu, S.; Jaoua, S.; Migheli, Q. Adsorption of Ochratoxin A from grape juice by yeast cells immobilised in calcium alginate beads. Int. J. Food Microbiol. 2016, 217, 29–34. [Google Scholar] [CrossRef]
  85. Fiori, S.; Urgeghe, P.P.; Hammami, W.; Razzu, S.; Jaoua, S.; Migheli, Q. Biocontrol activity of four non- and low-fermenting yeast strains against Aspergillus carbonarius and their ability to remove Ochratoxin A from grape juice. Int. J. Food Microbiol. 2014, 189, 45–50. [Google Scholar] [CrossRef]
  86. Angioni, A.; Caboni, P.; Garau, A.; Farris, A.; Orro, D.; Budroni, M.; Cabras, P. In vitro interaction between Ochratoxin A and different strains of Saccharomyces cerevisiae and Kloeckera apiculata. J. Agric. Food Chem. 2007, 55, 2043–2048. [Google Scholar] [CrossRef] [PubMed]
  87. Cecchini, F.; Morassut, M.; Garcia Moruno, E.; Di Stefano, R. Influence of yeast strain on Ochratoxin A content during fermentation of white and red must. Food Microbiol. 2006, 23, 411–417. [Google Scholar] [CrossRef]
  88. Zhu, R.; Feussner, K.; Wu, T.; Yan, F.; Karlovsky, P.; Zheng, X. Detoxification of mycotoxin patulin by the yeast Rhodosporidium paludigenum. Food Chem. 2015, 179 (Suppl. C), 1–5. [Google Scholar] [CrossRef] [PubMed]
  89. Ianiri, G.; Idnurm, A.; Castoria, R. Transcriptomic responses of the basidiomycete yeast Sporobolomyces sp. to the mycotoxin patulin. BMC Genom. 2016, 17, 210. [Google Scholar] [CrossRef] [PubMed]
  90. Castoria, R.; Morena, V.; Caputo, L.; Panfili, G.; De Curtis, F.; De Cicco, V. Effect of the biocontrol yeast Rhodotorula glutinis strain LS11 on patulin accumulation in stored apples. Phytopathology 2005, 95, 1271–1278. [Google Scholar] [CrossRef]
  91. Wang, J.; Zhang, H.; Yang, Q. Screening and identification of microorganisms for Ochratoxin A degradation. Food Sci. 2014, 35, 154–158. [Google Scholar]
  92. Xia, X.; Zhang, Y.; Li, M.; Garba, B.; Zhang, Q.; Wang, Y.; Zhang, H.; Li, P. Isolation and characterization of a Bacillus subtilis strain with aflatoxin B1 biodegradation capability. Food Control 2017, 75, 92–98. [Google Scholar] [CrossRef]
  93. Gerbaldo, G.A.; Barberis, C.; Pascual, L.; Dalcero, A.; Barberis, L. Antifungal activity of two Lactobacillus strains with potential probiotic properties. FEMS Microbiol. Lett. 2012, 332, 27–33. [Google Scholar] [CrossRef]
  94. Kabak, B.; Var, I. Factors affecting the removal of aflatoxin M1 from food model by Lactobacillus and Bifidobacterium strains. J. Environ. Sci. Health Part B 2008, 43, 617–624. [Google Scholar] [CrossRef]
  95. Shantha, T. Fungal degradation of aflatoxin B1. Nat. Toxins 1999, 7, 175–178. [Google Scholar] [CrossRef]
  96. Zhang, X.; Guo, Y.; Ma, Y.; Chai, Y.; Li, Y. Biodegradation of patulin by a Byssochlamys nivea strain. Food Control 2016, 64 (Suppl. C), 142–150. [Google Scholar] [CrossRef]
  97. Bejaoui, H.; Mathieu, F.; Taillandier, P.; Lebrihi, A. Biodegradation of Ochratoxin A by Aspergillus section Nigri species isolated from French grapes: A potential means of Ochratoxin A decontamination in grape juices and musts. FEMS Microbiol. Lett. 2006, 255, 203–208. [Google Scholar] [CrossRef]
  98. Xiong, K.; Wang, X.-L.; Zhi, H.-W.; Sun, B.-G.; Li, X.-T. Identification and safety evaluation of a product from the biodegradation of Ochratoxin A by an Aspergillus strain. J. Sci. Food Agric. 2017, 97, 434–443. [Google Scholar] [CrossRef] [PubMed]
  99. Cho, S.M.; Jeong, S.E.; Lee, K.R.; Sudhani, H.P.; Kim, M.; Hong, S.Y.; Chung, S.H. Biodegradation of Ochratoxin A by Aspergillus tubingensis Isolated from Meju. J. Microbiol. Biotechnol. 2016, 26, 1687–1695. [Google Scholar] [CrossRef]
  100. Valero, A.; Sanchis, V.; Ramos, A.J.; Marín, S. Brief in vitro study on Botrytis cinerea and Aspergillus carbonarius regarding growth and Ochratoxin A. Lett. Appl. Microbiol. 2008, 47, 327–332. [Google Scholar] [CrossRef]
  101. Bejaoui, H.; Mathieu, F.; Taillandier, P.; Lebrihi, A. Conidia of black Aspergilli as new biological adsorbents for Ochratoxin A in grape juices and musts. J. Agric. Food Chem. 2005, 53, 8224–8229. [Google Scholar] [CrossRef] [PubMed]
  102. Abrunhosa, L.; Serra, R.; Venâncio, A. Biodegradation of Ochratoxin A by fungi isolated from grapes. J. Agric. Food Chem. 2002, 50, 7493–7496. [Google Scholar] [CrossRef]
  103. Varga, J.; Péteri, Z.; Tábori, K.; Téren, J.; Vágvölgyi, C. Degradation of Ochratoxin A and other mycotoxins by Rhizopus isolates. Int. J. Food Microbiol. 2005, 99, 321–328. [Google Scholar] [CrossRef]
  104. De Felice, D.V.; Solfrizzo, M.; De Curtis, F.; Lima, G.; Visconti, A.; Castoria, R. Strains of Aureobasidium pullulans can lower Ochratoxin A contamination in wine grapes. Phytopathology 2008, 98, 1261–1270. [Google Scholar] [CrossRef]
  105. Engelhardt, G. Degradation of Ochratoxin A and B by the white rot fungus Pleurotus ostreatus. Mycotoxin Res. 2002, 18, 37–43. [Google Scholar] [CrossRef]
  106. Chen, Y.; Peng, H.-M.; Wang, X.; Li, B.-Q.; Long, M.-Y.; Tian, S.-P. Biodegradation Mechanisms of Patulin in Candida guilliermondii: An iTRAQ-Based Proteomic Analysis. Toxins 2017, 9, 48. [Google Scholar] [CrossRef] [PubMed]
  107. Var, I.; Erginkaya, Z.; Kabak, B. Reduction of Ochratoxin A Levels in White Wine by Yeast Treatments. J. Ins. Brewing. 2009, 115, 30–34. [Google Scholar] [CrossRef]
  108. Abrunhosa, L.; Paterson, R.R.; Venâncio, A. Biodegradation of Ochratoxin A for food and feed decontamination. Toxins 2010, 2, 1078–1099. [Google Scholar] [CrossRef]
  109. Abrunhosa, L.; Santos, L.; Venâncio, A. Degradation of Ochratoxin A by proteases and by a crude enzyme of Aspergillus niger. Food Biotechnol. 2006, 20, 231–242. [Google Scholar] [CrossRef]
  110. Deberghes, P.; Betbeder, A.M.; Boisard, F.; Blanc, R.; Delaby, J.F.; Krivobok, S.; Steiman, R.; Seigle-Murandi, F.; Creppy, E.E. Detoxification of Ochratoxin A, a food contaminant: Prevention of growth of Aspergillus ochraceus and its production of Ochratoxin A. Mycotoxin Res. 1995, 11, 37–47. [Google Scholar] [CrossRef]
  111. Pitout, M.J. The hydrolysis of ochratoxin A by some proteolytic enzymes. Biochem. Pharmacol. 1969, 18, 485–491. [Google Scholar] [CrossRef]
  112. Liuzzi, V.C.; Fanelli, F.; Tristezza, M.; Haidukowski, M.; Picardi, E.; Manzari, C.; Lionetti, C.; Grieco, F.; Logrieco, A.F.; Thon, M.R.; et al. Transcriptional analysis of Acinetobacter sp. neg1 capable of degrading Ochratoxin A. Front. Microbiol. 2016, 7, 2162. [Google Scholar] [CrossRef]
  113. Abrunhosa, L.; Venâncio, A.; Teixeira, J.A. Optimization of process parameters for the production of an OTA-hydrolyzing enzyme from Aspergillus niger under solid-state fermentation. J. Biosci. Bioeng. 2011, 112, 351–355. [Google Scholar] [CrossRef]
  114. Stander, M.A.; Bornscheuer, U.T.; Henke, E.; Steyn, P.S. Screening of commercial hydrolases for the degradation of Ochratoxin A. J. Agric. Food Chem. 2000, 48, 5736–5739. [Google Scholar] [CrossRef]
  115. Abrunhosa, L.; Venancio, A. Isolation and purification of an enzyme hydrolyzing ochratoxin A from Aspergillus niger. Biotechnol. Lett. 2007, 29, 1909–1914. [Google Scholar] [CrossRef]
  116. Sun, F.; Yu, D.; Zhou, H.; Lin, H.; Yan, Z.; Wu, A. CotA laccase from bacillus licheniformis ZOM-1 effectively degrades zearalenone, aflatoxin B1 and alternariol. Food Control 2023, 145, 109472. [Google Scholar] [CrossRef]
  117. Tittlemier, S.; Cramer, B.; Dall’Asta, C.; Iha, M.; Lattanzio, V.; Maragos, C.; Solfrizzo, M.; Stranska-Zachariasova, M.; Stroka, J. Developments in mycotoxin analysis: An update for 2018-19. World Mycotoxin J. 2020, 13, 3–24. [Google Scholar]
  118. Chen, Y.; Xing, M.; Chen, T.; Tian, S.; Li, B. Effects and mechanisms of plant bioactive compounds in preventing fungal spoilage and mycotoxin contamination in postharvest fruits: A review. Food Chem. 2023, 415, 135787. [Google Scholar] [CrossRef]
  119. Pereyra, C.M.; Cavaglieri, L.R.; Keller, K.M.; Chiacchera, S.M.; Rosa, C.A.D.R.; Dalcero, A.M. In vitro Ochratoxin A adsorption by commercial yeast cell walls. Rev. Bras. Med. Vet. 2015, 37, 25–28. [Google Scholar]
  120. Caridi, A.; Sidari, R.; Pulvirenti, A.; Meca, G.; Ritieni, A. Ochratoxin A adsorption phenotype: An inheritable yeast trait. J. Gen. Appl. Microbiol. 2012, 58, 225–233. [Google Scholar] [CrossRef] [PubMed]
  121. Armando, M.R.; Pizzolitto, R.P.; Dogi, C.A.; Cristofolini, A.; Merkis, C.; Poloni, V.; Dalcero, A.M.; Cavaglieri, L.R. Adsorption of Ochratoxin A and zearalenone by potential probiotic Saccharomyces cerevisiae strains and its relation with cell wall thickness. J. Appl. Microbiol. 2012, 113, 256–264. [Google Scholar]
  122. Piotrowska, M. Adsorption of Ochratoxin A by Saccharomyces cerevisiae living and non-living cells. Acta Aliment. 2012, 41, 1–7. [Google Scholar] [CrossRef]
  123. Karlovsky, P. Biological detoxification of fungal toxins and its use in plant breeding, feed and food production. Nat. Toxins 1999, 7, 1–23. [Google Scholar] [CrossRef]
  124. Xiao, H.; Madhyastha, S.; Marquardt, R.R.; Li, S.; Vodela, J.K.; Frohlich, A.A.; Kemppainen, B.W. Toxicity of ochratoxin A, its opened lactone form and several of its analogs: Structure–activity relationships. Toxicol. Appl. Pharmacol. 1996, 137, 182–192. [Google Scholar]
  125. Li, S.; Marquardt, R.R.; Frohlich, A.A.; Vitti, T.G.; Crow, G. Pharmacokinetics of ochratoxin A and its metabolites in rats. Toxicol. Appl. Pharmacol. 1997, 145, 82–90. [Google Scholar] [CrossRef]
  126. Binder, E.M.; Heidler, D.; Schatzmayr, G.; Thimm, N.; Fuchs, E.; Schuh, M. Microbial detoxification of mycotoxins in animal feed. In Proceedings of the 10th International IUPAC Symposium on Mycotoxins and Phycotoxins, Guarujá, Brazil, 21–25 May 2000; De Koe, W.J., Samson, R.A., Van Egmond, H.J., Gilbert, J., Sabino, M., Eds.; Ponsen and Looyen: Wageningen, The Netherlands, 2000. [Google Scholar]
  127. Hanif, N.Q.; Muhammad, G.; Siddique, M.; Khanum, A.; Ahmed, T.; Gadahai, J.A.; Kaukab, G. Clinico-pathomorphological, serum biochemical and histological studies in broilers fed Ochratoxin A and a toxin deactivator (Mycofix® Plus). Br. Poult. Sci. 2008, 49, 632–642. [Google Scholar] [CrossRef] [PubMed]
  128. Csutorás, C.; Rácz, L.; Rácz, K.; Futo, P.; Forgó, P.; Kiss, A. Monitoring of Ochratoxin A during the fermentation of different wines by applying high toxin concentrations. Microchem. J. 2013, 107, 182–184. [Google Scholar] [CrossRef]
  129. Moruno, E.G.; Sanlorenzo, C.; Boccaccino, B.; Di Stefano, R. Treatment with yeast to reduce the concentration of Ochratoxin A in red wine. Am. J. Enol. Viticult. 2005, 56, 73–76. [Google Scholar] [CrossRef]
  130. Slizewska, K.; Piotrowska, M. Reduction of Ochratoxin A in chicken feed using probiotic. Ann. Agric. Environ. Med. 2014, 21, 676–680. [Google Scholar] [CrossRef] [PubMed]
  131. Zhou, T.; Chu, C.-L.; Liu, W.T.; Schaneider, K.E. Postharvest control of blue mold and gray mold on apples using isolates of Pseudomonas syringae. Can. J. Plant Pathol. 2001, 23, 246–252. [Google Scholar] [CrossRef]
  132. Guo, C.; Yuan, Y.; Yue, T.; Hatab, S.; Wang, Z. Binding mechanism of patulin to heat-treated yeast cell. Lett. Appl. Microbiol. 2012, 55, 453–459. [Google Scholar] [CrossRef]
  133. Wang, L.; Wang, Z.; Yuan, Y.; Cai, R.; Niu, C.; Yue, T. Identification of Key Factors Involved in the Biosorption of Patulin by Inactivated Lactic Acid Bacteria (LAB) Cells. PLoS ONE 2015, 10, e0143431. [Google Scholar] [CrossRef] [PubMed]
  134. Folger, B.C. Patulin Degradation by Yeast Protein Extract. Master’s Thesis, University of Minnesota, Minneapolis, MN, USA, 2014; p. 83. [Google Scholar]
  135. Luz, C.; Saladino, F.; Luciano, F.B.; Mañes, J.; Meca, G. In vitro antifungal activity of bioactive peptides produced by Lactobacillus plantarum against Aspergillus parasiticus and Penicillium expansum. LWT—Food Sci. Technol. 2017, 81 (Suppl. C), 128–135. [Google Scholar] [CrossRef]
  136. Zheng, X.; Yang, Q.; Zhang, H.; Cao, J.; Zhang, X.; Apaliya, M.T. The Possible Mechanisms Involved in Degradation of Patulin by Pichia caribbica. Toxins 2016, 8, 289. [Google Scholar] [CrossRef]
  137. Zheng, X.; Yang, Q.; Zhang, X.; Apaliya, M.T.; Ianiri, G.; Zhang, H.; Castoria, R. Biocontrol Agents Increase the Specific Rate of Patulin Production by Penicillium expansum but Decrease the Disease and Total Patulin Contamination of Apples. Front. Microbiol. 2017, 8, 1240. [Google Scholar] [CrossRef]
  138. Castoria, R.; Mannina, L.; Durán-Patrón, R.; Maffei, F.; Sobolev, A.P.; De Felice, D.V.; Pinedo-Rivilla, C.; Ritieni, A.; Ferracane, R.; Wright, S.A. Conversion of the mycotoxin patulin to the less toxic desoxypatulinic acid by the biocontrol yeast Rhodosporidium kratochvilovae strain LS11. J. Agric. Food Chem. 2011, 59, 11571–11578. [Google Scholar] [CrossRef] [PubMed]
  139. Dobritzsch, D.; Wang, H.; Schneider, G.; Yu, S. Structural and functional characterization of ochratoxinase, a novel mycotoxin-degrading enzyme. Biochem. J. 2014, 462, 441–452. [Google Scholar] [CrossRef] [PubMed]
  140. Cole, R.J.; Cotty, P.J. Biocontrol of aflatoxin production by using biocompetitive agents. In A Perspective on Aflatoxin in Field Crops and Animal Food Products in the United States: A Symposium; Robins, J.F., Ed.; USDA-ARS: Washington, DC, USA, 1990; pp. 62–66. [Google Scholar]
  141. Moral, J.; Garcia-Lopez, M.T.; Camiletti, B.X.; Jaime, R.; Michailides, T.J.; Bandyopadhyay, R.; Ortega-Beltran, A. Present status and perspective on the future use of aflatoxin biocontrol products. Agronomy 2020, 10, 491. [Google Scholar] [CrossRef]
  142. Cotty, P.; Bayman, P. Competitive exclusion of a toxigenic strain of Aspergillus flavus by an atoxigenic strain. Phytopathology 1993, 83, 1283–1287. [Google Scholar] [CrossRef]
  143. Shabeer, S.; Asad, S.; Jamal, A.; Ali, A. Aflatoxin Contamination, Its Impact and Management Strategies: An Updated Review. Toxins 2022, 14, 307. [Google Scholar] [CrossRef]
  144. Okun, D.O.; Khamis, F.M.; Muluvi, G.M.; Ngeranwa, J.J.; Ombura, F.O.; Yongo, M.O.; Kenya, E.U. Distribution of indigenous strains of atoxigenic and toxigenic Aspergillus flavus and Aspergillus parasiticus in maize and peanuts agro-ecological zones of Kenya. Agric. Food Secur. 2015, 4, 1–10. [Google Scholar] [CrossRef]
  145. Abbas, H.K.; Zablotowicz, R.M.; Bruns, H.A.; Abel, C.A. Biocontrol of aflatoxin in corn by inoculation with non-aflatoxigenic Aspergillus flavus isolates. Biocontrol Sci. Technol. 2006, 16, 437–449. [Google Scholar] [CrossRef]
  146. Cotty, P.J. Development of Aspergillus flavus AF36. 2005. Available online: https://biopesticide.ucr.edu/abstracts/assets/Cotty_abstract.pdf (accessed on 5 February 2024).
  147. Ren, X.; Zhang, Q.; Zhang, W.; Mao, J.; Li, P. Control of Aflatoxigenic Molds by Antagonistic Microorganisms: Inhibitory Behaviors, Bioactive Compounds, Related Mechanisms, and Influencing Factors. Toxins 2020, 12, 24. [Google Scholar] [CrossRef]
  148. Kong, Q.; Chi, C.; Yu, J.; Shan, S.; Li, Q.; Li, Q.; Guan, B.; Nierman, W.C.; Bennett, J.W. The inhibitory effect of Bacillus megaterium on aflatoxin and cyclopiazonic acid biosynthetic pathway gene expression in Aspergillus flavus. Appl. Microbiol. Biotechnol. 2014, 98, 5161–5172. [Google Scholar] [CrossRef]
  149. Siahmoshteh, F.; Hamidi-Esfahani, Z.; Spadaro, D.; Shams-Ghahfarokhi, M.; Razzaghi-Abyaneh, M. Unraveling the mode of antifungal action of Bacillus subtilis and Bacillus amyloliquefaciens as potential biocontrol agents against aflatoxigenic Aspergillus parasiticus. Food Control 2018, 89, 300–307. [Google Scholar] [CrossRef]
  150. Ndiaye, S.; Zhang, M.; Fall, M.; Ayessou, N.M.; Zhang, Q.; Li, P. Current Review of Mycotoxin Biodegradation and Bioadsorption: Microorganisms, Mechanisms, and Main Important Applications. Toxins 2022, 14, 729. [Google Scholar] [CrossRef] [PubMed]
  151. González Pereyra, M.L.; Martínez, M.P.; Petroselli, G.; Erra Balsells, R.; Cavaglieri, L.R. Antifungal and aflatoxin-reducing activity of extracellular compounds produced by soil Bacillus strains with potential application in agriculture. Food Control 2018, 85, 392–399. [Google Scholar] [CrossRef]
  152. Palumbo, J.D.; O’Keeffe, T.L.; Abbas, H.K. Isolation of maize soil and rhizosphere bacteria with antagonistic activity against Aspergillus flavus and Fusarium verticillioides. J. Food Prot. 2007, 70, 1615–1621. [Google Scholar] [CrossRef] [PubMed]
  153. Mander, P.; Cho, S.S.; Choi, Y.H.; Panthi, S.; Choi, Y.S.; Kim, H.M.; Yoo, J.C. Purification and characterization of chitinase showing antifungal and biodegradation properties obtained from Streptomyces anulatus CS242. Arch. Pharm. Res. 2016, 39, 878–886. [Google Scholar] [CrossRef]
  154. Wang, C.; Wang, Z.; Qiao, X.; Li, Z.; Li, F.; Chen, M.; Wang, Y.; Huang, Y.; Cui, H. Antifungal activity of volatile organic compounds from Streptomyces alboflavus TD-1. FEMS Microbiol. Lett. 2013, 341, 45–51. [Google Scholar] [CrossRef]
  155. Caceres, I.; Snini, S.P.; Puel, O.; Mathieu, F. Streptomyces roseolus, A Promising Biocontrol Agent Against Aspergillus flavus, the Main Aflatoxin B1 Producer. Toxins 2018, 10, 442. [Google Scholar] [CrossRef]
  156. Taylor, W.J.; Draughon, F.A. Nannocystis exedens: A potential biocompetitive agent against Aspergillus flavus and Aspergillus parasiticus. J. Food Prot. 2001, 64, 1030–1034. [Google Scholar] [CrossRef]
  157. Anjaiah, V.; Thakur, R.P.; Koedam, N. Evaluation of bacteria and Trichoderma for biocontrol of pre-harvest seed infection by Aspergillus flavus in groundnut. Biocontrol Sci. Technol. 2007, 16, 431–436. [Google Scholar] [CrossRef]
  158. Dorner, J.W.; Cole, R.J.; Connick, W.J.; Daigle, D.J.; McGuire, M.R.; Shasha, B.S. Evaluation of biological control formulations to reduce aflatoxin contamination in peanuts. Biol. Control 2003, 26, 318–324. [Google Scholar] [CrossRef]
  159. Cotty, P.J. Influence of field application of an atoxigenic strain of Aspergillus flavus on the populations of A. flavus infecting cotton bolls and on the aflatoxin content of cottonseed. Phytopathology 1994, 84, 1270–1277. [Google Scholar]
  160. Alaniz Zanon, M.S.; Paz Clemente, M.; Noemi Chulze, S. Characterization and competitive ability of non-aflatoxigenic Aspergillus flavus isolated from the maize agro-ecosystem in Argentina as potential aflatoxin biocontrol agents. Int. J. Food Microbiol. 2018, 277, 58–63. [Google Scholar] [CrossRef]
  161. Dorner, J.W.; Cole, R.J. Effect of application of nontoxigenic strains of Aspergillus flavus and A-parasiticus on subsequent aflatoxin contamination of peanuts in storage. J. Stored Prod. Res. 2002, 38, 329–339. [Google Scholar] [CrossRef]
  162. Mondol, M.A.; Shin, H.J.; Islam, M.T. Diversity of secondary metabolites from marine Bacillus species: Chemistry and biological activity. Mar. Drugs 2013, 11, 2846–2872. [Google Scholar] [CrossRef] [PubMed]
  163. Zhao, H.; Shao, D.; Jiang, C.; Shi, J.; Li, Q.; Huang, Q.; Rajoka, M.S.R.; Yang, H.; Jin, M. Biological activity of lipopeptides from Bacillus. Appl. Microbiol. Biotechnol. 2017, 101, 5951–5960. [Google Scholar] [CrossRef]
  164. Guimaraes, A.; Santiago, A.; Teixeira, J.A.; Venancio, A.; Abrunhosa, L. Anti-aflatoxigenic effect of organic acids produced by Lactobacillus plantarum. Int. J. Food Microbiol. 2018, 264, 31–38. [Google Scholar] [CrossRef] [PubMed]
  165. Russo, P.; Arena, M.P.; Fiocco, D.; Capozzi, V.; Drider, D.; Spano, G. Lactobacillus plantarum with broad antifungal activity: A promising approach to increase safety and shelf-life of cereal-based products. Int. J. Food Microbiol. 2017, 247, 48–54. [Google Scholar] [CrossRef]
  166. Armando, M.R.; Dogi, C.A.; Rosa, C.A.; Dalcero, A.M.; Cavaglieri, L.R. Saccharomyces cerevisiae strains and the reduction of Aspergillus parasiticus growth and aflatoxin B1 production at different interacting environmental conditions, in vitro. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2012, 29, 1443–1449. [Google Scholar] [CrossRef]
  167. Peromingo, B.; Andrade, M.J.; Delgado, J.; Sanchez-Montero, L.; Nunez, F. Biocontrol of aflatoxigenic Aspergillus parasiticus by native Debaryomyces hansenii in dry-cured meat products. Food Microbiol. 2019 82, 269–276. [CrossRef]
  168. Deng, J.J.; Huang, W.Q.; Li, Z.W.; Lu, D.L.; Zhang, Y.; Luo, X.C. Biocontrol activity of recombinant aspartic protease from Trichoderma harzianum against pathogenic fungi. Enzym. Microb. Technol. 2018, 112, 35–42. [Google Scholar] [CrossRef]
  169. Munimbazi, C.; Bullerman, L.B. Inhibition of aflatoxin production of Aspergillus parasiticus NRRL 2999 by Bacillus pumilus. Mycopathologia 1998, 140, 163–169. [Google Scholar] [CrossRef]
  170. Wallace, R.L.; Hirkala, D.L.; Nelson, L.M. Postharvest biological control of blue mold of apple by Pseudomonas fluorescens during commercial storage and potential modes of action. Postharvest Biol. Technol. 2017, 133 (Suppl. C), 1–11. [Google Scholar] [CrossRef]
  171. Narayanasamy, P.; Narayanasamy, P. Mechanisms of action of fungal biological control agents. In Biological Management of Diseases of Crops; Characteristics of Biological Control Agents; Hokkanen, H., Gao, Y., Eds.; Springer: Dordrecht, The Netherlands, 2013; Volume 1, pp. 99–200. [Google Scholar]
  172. Illueca, F.; Vila-Donat, P.; Calpe, J.; Luz, C.; Meca, G.; Quiles, J.M. Antifungal Activity of Biocontrol Agents In Vitro and Potential Application to Reduce Mycotoxins (Aflatoxin B1 and Ochratoxin A). Toxins. 2021, 13, 752. [Google Scholar] [CrossRef] [PubMed]
  173. Ghanbari, R.; Molaee Aghaee, E.; Rezaie, S.; Jahed Khaniki, G.; Alimohammadi, M.; Soleimani, M.; Noorbakhsh, F. The inhibitory effect of lactic acid bacteria on aflatoxin production and expression of aflR gene in Aspergillus parasiticus. J. Food Saf. 2018, 38, e12413. [Google Scholar] [CrossRef]
  174. Ahlberg, S.; Joutsjoki, V.; Laurikkala, S.; Varmanen, P.; Korhonen, H. Aspergillus flavus growth inhibition by Lactobacillus strains isolated from traditional fermented Kenyan milk and maize products. Arch. Microbiol. 2017, 199, 457–464. [Google Scholar] [CrossRef]
  175. Gerez, C.L.; Torres, M.J.; Font de Valdez, G.; Rollán, G. Control of spoilage fungi by lactic acid bacteria. Biol. Control 2013, 64, 231–237. [Google Scholar] [CrossRef]
  176. Ngang, J.-J.E.; Yadang, G.; Kamdem, S.L.S.; Kouebou, C.P.; Fanche, S.A.Y.; Kougan, D.L.T.; Tsoungui, A.; Etoa, F.X. Antifungal properties of selected lactic acid bacteria and application in the biological control of ochratoxin A producing fungi during cocoa fermentation. Biocontrol. Sci. Technol. 2015, 25, 245–259. [Google Scholar] [CrossRef]
  177. Yang, X.; Zhang, Q.; Chen, Z.-Y.; Liu, H.; Li, P. Investigation of Pseudomonas fluorescens strain 3JW1 on preventing and reducing aflatoxin contaminations in peanuts. PLoS ONE 2017, 12, e0178810. [Google Scholar] [CrossRef]
  178. Akocak, P.B.; Churey, J.J.; Worobo, R.W. Antagonistic effect of chitinolytic Pseudomonas and Bacillus on growth of fungal hyphae and spores of aflatoxigenic Aspergillus flavus. Food Biosci. 2015, 10, 48–58. [Google Scholar] [CrossRef]
  179. Mannaa, M.; Oh, J.; Kim, K.D. Microbe-mediated control of Aspergillus flavus in stored rice grains with a focus on aflatoxin inhibition and biodegradation. Ann. Appl. Biol. 2017, 171, 376–392. [Google Scholar] [CrossRef]
  180. Wang, K.; Yan, P.S.; Cao, L.; Ding, Q.; Shao, C.; Zhao, T.F. Potential of chitinolytic Serratia marcescens strain JPP1 for biological control of Aspergillus parasiticus and aflatoxin. BioMed Res. Int. 2013, 397142. [Google Scholar] [CrossRef]
  181. Coelho, A.R.; Tachi, M.; Pagnocca, F.C.; Nobrega, G.M.; Hoffmann, F.L.; Harada, K.; Hirooka, E.Y. Purification of Candida guilliermondii and Pichia ohmeri killer toxin as an active agent against Penicillium expansum. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2009, 26, 73–81. [Google Scholar] [CrossRef] [PubMed]
  182. Pitt, J.; Hocking, A.D. Mycotoxins in Australia: Biocontrol of aflatoxin in peanuts. Mycopathologia 2006, 162, 233–243. [Google Scholar] [CrossRef] [PubMed]
  183. Dorner, J.; Lamb, M.C. Development and commercial use of afla-Guard®, an aflatoxin biocontrol agent. Mycotoxin Res. 2006, 22, 33–38. [Google Scholar] [CrossRef]
  184. Cardwell, K.F.; Henry, S.H. Risk of exposure to and mitigation of effect of aflatoxin on human health: A West African example. J. Toxicol. Toxin. Rev. 2004, 23, 217–247. [Google Scholar] [CrossRef]
  185. Yin, Y.; Yan, L.; Jiang, J.; Ma, Z. Biological control of aflatoxin contamination of crops. J. Zhejiang Univ. Sci. 2008, 9, 787–792. [Google Scholar] [CrossRef] [PubMed]
  186. Zanon, M.S.A.; Barros, G.G.; Chulze, S.N. Non-aflatoxigenic Aspergillus flavus as potential biocontrol agents to reduce aflatoxin contamination in peanuts harvested in Northern Argentina. Int. J. Food Microbiol. 2016, 231, 63–68. [Google Scholar] [CrossRef]
  187. Xing, F.; Wang, L.; Liu, X.; Selvaraj, J.N.; Wang, Y.; Zhao, Y.; Liu, Y. Aflatoxin B1 inhibition in Aspergillus flavus by Aspergillus niger through down-regulating expression of major biosynthetic genes and AFB1 degradation by atoxigenic A. flavus. Int. J. Food Microbiol. 2017, 256, 1–10. [Google Scholar] [CrossRef]
  188. Xu, D.; Wang, H.; Zhang, Y.; Yang, Z.; Sun, X. Inhibition of non-toxigenic Aspergillus niger FS10 isolated from Chinese fermented soybean on growth and aflatoxin B1 production by Aspergillus flavus. Food Control 2013, 32, 359–365. [Google Scholar] [CrossRef]
  189. Bernáldez, V.; Rodríguez, A.; Martín, A.; Lozano, D.; Córdoba, J.J. Development of a multiplex qPCR method for simultaneous quantification in dry-cured ham of an antifungal-peptide Penicillium chrysogenum strain used as protective culture and aflatoxinproducing moulds. Food Control 2014, 36, 257–265. [Google Scholar] [CrossRef]
  190. Mostafa, A.A.; Al-Rahmah, A.N.; Abdel-Megeed, A.; Sayed, S.R.; Hatamleh, A.A. Antagonistic activities of some fungal strains against the toxigenic Aspergillus flavus isolate and its aflatoxins productivity. J. Pure Appl. Microbiol. 2013, 7, 169–178. [Google Scholar]
  191. Coelho, A.R.; Celli, M.G.; Ono, E.Y.S.; Wosiacki, G.; Hoffmann, F.L.; Pagnocca, F.C.; Hirooka, E.Y. Penicillium expansum versus antagonist yeasts and patulin degradation in vitro. Braz. Arch. Biol. Technol. 2007, 50, 725–733. [Google Scholar] [CrossRef]
  192. Cao, J.; Zhang, H.; Yang, Q.; Ren, R. Efficacy of Pichia caribbica in controlling blue mold rot and patulin degradation in apples. Int. J. Food Microbiol. 2013, 162, 167–173. [Google Scholar] [CrossRef] [PubMed]
  193. Morales, H.; Sanchis, V.; Usall, J.; Ramos, A.J.; Marín, S. Effect of biocontrol agents Candida sake and Pantoea agglomerans on Penicillium expansum growth and patulin accumulation in apples. Int. J. Food Microbiol. 2008, 122, 61–67. [Google Scholar] [CrossRef] [PubMed]
  194. Farahani, L.; Etebarian, H.R.; Sahebani, N.; Aminian, H. Biocontrol of blue mold of apple by Candida membranifaciens in combination with silicon. Arch. Phytopathol. Plant Prot. 2012, 45, 310–317. [Google Scholar]
  195. Ebrahimi, L.; Aminian, H.; Etebarian, H.R.; Sahebani, N. Control of apple blue mould disease with Torulaspora delbrueckii in combination with Silicon. Arch. Phytopathol. Plant Prot. 2012, 45, 2057–2065. [Google Scholar]
  196. Pimenta, R.S.; Silva, F.; Silva, J.F.M.; Morais, P.B.; Braga, D.T.; Rosa, C.A.; Corrêa, A., Jr. Biological control of Penicillium italicum, P. digitatum and P. expansum by the predacious yeast Saccharomycopsis schoenii on oranges. Braz. J. Microbiol. 2008, 39, 85–90. [Google Scholar] [CrossRef]
  197. Palumbo, J.D.; O’Keeffe, T.L.; Mahoney, N.E. Inhibition of ochratoxin A production and growth of Aspergillus species by phenolic antioxidant compounds. Mycopathologia 2007, 164, 241–248. [Google Scholar]
  198. Valencia-Quintana, R.; Milić, M.; Jakšić, D.; Šegvić Klarić, M.; Tenorio- Arvide, M.G.; Pérez-Flores, G.A.; Bonassi, S.; Sánchez-Alarcón, J. Environment changes, aflatoxins, and health issues, a review. Int. J. Environ. Res. Public Health 2020, 17, 7850. [Google Scholar]
  199. Shen, Y.; Nie, J.; Li, Z.; Li, H.; Wu, Y.; Zhang, J. Research progress on contamination, toxicity, biosynthesis and influencing factors of mycotoxins in fruits. Shipin Kexue 2018, 9, 294–304. [Google Scholar]
  200. Zhou, W.; Hu, L.; Zhao, Y.; Wang, M.Y.; Zhang, H.; Mo, H. Inhibition of fungal aflatoxin B1 biosynthesis by diverse botanically-derived polyphenols. Trop. J. Pharm. Res. 2015, 14, 605–609. [Google Scholar] [CrossRef]
  201. Sivakumar, D.; Bautista-Baños, S. A review on the use of essential oils for postharvest decay control and maintenance of fruit quality during storage. Crop Prot. 2014, 64, 27–37. [Google Scholar] [CrossRef]
  202. Chtioui, W.; Heleno, S.; Migheli, Q.; Rodrigues, P. Plant extracts as biocontrol agents against Aspergillus carbonarius growth and ochratoxin A production in grapes. Int. J. Food Microbiol. 2023, 407, 110425. [Google Scholar] [CrossRef]
  203. Kadoglidou, K.; Lagopodi, A.; Karamanoli, K.; Vokou, D.; Bardas, G.A.; Menexes, G.; Constantinidou, H.I.A. Inhibitory and stimulatory effects of essential oils and individual monoterpenoids on growth and sporulation of four soil-borne fungal isolates of Aspergillus terreus, Fusarium oxysporum, Penicillium expansum, and Verticillium dahliae. Eur. J. Plant Pathol. 2011, 130, 297–309. [Google Scholar] [CrossRef]
  204. Reverberi, M.; Fabbri, A.; Zjalic, S.; Ricelli, A.; Punelli, F.; Fanelli, C. Antioxidant enzymes stimulation in Aspergillus parasiticus by Lentinula edodes inhibits aflatoxin production. Appl. Microbiol. Biotechnol. 2005, 69, 207–215. [Google Scholar] [CrossRef]
  205. Ikeura, H.; Somsak, N.; Kobayashi, F.; Kanlayanarat, S.; Hayata, Y. Application of selected plant extracts to inhibit growth of Penicillium expansum on apple fruits. Plant Pathol. J. 2011, 10, 79–84. [Google Scholar] [CrossRef]
  206. Ren, X.; Branà, M.T.; Haidukowski, M.; Gallo, A.; Zhang, Q.; Logrieco, A.F.; Li, P.; Zhao, S.; Altomare, C. Potential of Trichoderma spp. for Biocontrol of Aflatoxin-Producing Aspergillus flavus. Toxins 2022, 14, 86. [Google Scholar] [CrossRef] [PubMed]
  207. Morales, H.; Marín, S.; Ramos, A.J.; Sanchis, V. Influence of postharvest technologies applied during cold storage of apples in Penicillium expansum growth and patulin accumulation: A review. Food Control 2010, 21, 953–962. [Google Scholar] [CrossRef]
  208. Stoev, S.D.; Angelov, G.; Pavlov, D.; Pirovski, L. Some antidotes and paraclinical Investigations in experimental intoxication with ochratoxin A and penicillic acid in chicks. Vet. Arhiv. 1999, 69, 179–189. [Google Scholar]
  209. Stoev, S.D.; Djuvinov, D.; Mirtcheva, T.; Pavlov, D.; Mantle, P. Studies on some feed additives giving partial protection against ochratoxin A toxicity in chicks. Toxicol. Lett. 2002, 135, 33–50. [Google Scholar] [CrossRef]
  210. Stoev, S.D.; Stefanov, M.; Denev, S.; Radic, B.; Domijan, A.-M.; Peraica, M. Experimental mycotoxicosis in chickens induced by ochratoxin A and penicillic acid and intervention by natural plant extracts. Vet. Res. Commun. 2004, 28, 727–746. [Google Scholar] [CrossRef]
  211. Stoev, S.D.; Njobeh, P.; Zarkov, I.; Mircheva, T.; Zapryanova, D.; Denev, S.; Dimitrova, B. Selected herbal feed additives showing protective effects against ochratoxin A toxicosis in broiler chicks. World Mycotoxin J. 2019, 12, 257–268. [Google Scholar]
  212. Stoev, S.D.; Dimitrov, K.; Zarkov, I.; Mircheva, T.; Zapryanova, D.; Valchev, I.; Denev, S.; Chobanova, S.; Stefanov, M.; Arora, R. Some Indian herbs have protective effects against deleterious effects of ochratoxin A in broiler chicks. World Mycotoxin J. 2021, 14, 525–538. [Google Scholar] [CrossRef]
  213. Stoev, S.D.; Mircheva, T.; Denev, S.; Chobanova, S.; Ivanov, V. The Protective Effect of Silymarin against Ochratoxin A Induced Histopathological and Biochemical Changes in Chicks. J. Adv. Vet. Res. 2021, 11, 1–8. [Google Scholar]
  214. Stoev, S.D. Complex Etiology, Prophylaxis and Hygiene Control in Mycotoxic Nephropathies in Farm Animals and Humans, Special Issue “Mycotoxins: Mechanisms of Toxicological Activity—Treatment and Prevention”, Section “Molecular Pathology”. Int. J. Mol. Sci. 2008, 9, 578–605. [Google Scholar]
  215. Karamalakova, Y.; Agarwal, P.; Nikolova, G.; Adhikari, M.; Gupta, D.; Stoev, S.D.; Georgiev, T.; Hadzhibozheva, P.; Arora, R.; Zhelev, Z.; et al. Influence of ochratoxin-A and an extract of Tinospora cordifolia against biochemical and oxidative changes in mice spleen. Sci. Technol. Med. Biol. Stud. Clin. Stud. Soc. Med. Health Care 2016, 6, 242–251. [Google Scholar]
  216. Karamalakova, Y.; Nikolova, G.; Adhikari, M.; Stoev, S.D.; Agarwal, P.; Gadjeva, V.; Zhelev, Z. Oxidative-protective effects of Tinospora cordifolia extract on plasma and spleen cells after experimental ochratoxicosis. Comp. Clin. Pathol. 2018, 27, 1487–1495. [Google Scholar] [CrossRef]
  217. Mukherjee, P.K.; Wahile, A. Integrated approaches towards drug development from Ayurveda and other Indian system of medicines. J. Ethnopharma 2006, 103, 25–35. [Google Scholar] [CrossRef]
  218. Khatoon, A.; Khan, M.Z.; Khan, A.; Saleemi, M.K.; Javed, I. Amelioration of Ochratoxin A-induced immunotoxic effects by Silymarin and vitamin E in White Leghorn cockerels. J. Immunotoxicol. 2013, 10, 25–31. [Google Scholar] [CrossRef]
  219. Muhammad, D.; Chand, N.; Khan, S.; Sultan, A.; Mushtaq, M.; Rafiullah. Hepatoprotective role of milk thistle (Silybum marianum) in meat type chicken fed aflatoxin B1 contaminated feed. Pak. Vet. J. 2012, 32, 443–446. [Google Scholar]
  220. Tedesco, D.; Domeneghini, C.; Sciannimanico, D.; Tameni, M.; Steidler, S.; Galletti, S. Efficacy of Silymarin-phospholipid complex in reducing the toxicity of aflatoxin B1 in broiler chicks. J. Poult. Sci. 2004, 83, 1839–1843. [Google Scholar] [CrossRef]
  221. Soto, C.; Pérez, J.; García, V.; Uría, E.; Vadillo, M.; Raya, L. Effect of Silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus. Phytomedicine 2010, 17, 1090–1094. [Google Scholar] [CrossRef] [PubMed]
  222. Varzi, H.N.; Esmailzadeh, S.; Morovvati, H.; Avizeh, R.; Shahriari, A.; Givi, M.E. Effect of Silymarin and vitamin E on gentamicin-induced nephrotoxicity in dogs. J. Vet. Pharmacol. Ther. 2007, 30, 477–481. [Google Scholar] [CrossRef] [PubMed]
  223. Karimi, G.; Ramezani, M.; Tahoonian, Z. Cisplatin nephrotoxicity and protection by milk thistle extract in rats. J. Evid. Based Complement. Altern. Med. 2005, 2, 383–386. [Google Scholar] [CrossRef] [PubMed]
  224. Rasool, M.; Iqbal, J.; Malik, A.; Ramzan, H.S.; Qureshi, M.S.; Asif, M.; Qazi, M.H.; Kamal, M.A.; Chaudhary, A.G.A.; Al-Qahtani, M.H.; et al. Hepatoprotective Effects of Silybum marianum (Silymarin) and Glycyrrhiza glabra (Glycyrrhizin) in Combination: A Possible Synergy. Evid. Based Complement. Alternat. Med. 2014, 2014, 641597. [Google Scholar] [CrossRef]
  225. Shaarawy, S.M.; Tohamy, A.A.; Elgendy, S.M.; Abd Elmageed, Z.A.; Bahnasy, A.; Mohamed, M.S.; Kandil, E.; Matrougui, K. Protective effects of garlic and Silymarin on NDEA-induced rats hepatotoxicity. Int. J. Biol. Sci. 2009, 5, 549–557. [Google Scholar] [CrossRef]
  226. Kaur, M.; Agarwal, R. Silymarin and epithelial cancer chemoprevention: How close we are to bedside? Toxicol. Appl. Pharmacol. 2007, 224, 350–359. [Google Scholar] [CrossRef]
  227. Pradeep, K.; Mohan, C.V.; Gobianand, K.; Karthikeyan, S. Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats. Eur. J. Pharmacol. 2007, 560, 110–116. [Google Scholar] [CrossRef]
  228. Pradeep, K.; Mohan, C.V.; Gobianand, K.; Karthikeyan, S. Silymarin: An effective hepatoprotective agent against diethylnitrosamine-induced hepatotoxicity in rats. Pharm. Biol. 2007, 45, 707–714. [Google Scholar] [CrossRef]
  229. Kiruthiga, P.V.; Shafreen, R.B.; Pandian, S.K.; Devi, K.P. Silymarin protection against major reactive oxygen species released by environmental toxins: Exogenous H2O2 exposure in erythrocytes. Basic Clin. Pharmacol. Toxicol. 2007, 100, 414–419. [Google Scholar] [CrossRef]
  230. Kiruthiga, P.V.; Pandian, S.K.; Devi, K.P. Silymarin protects PBMC against B(a)P induced toxicity by replenishing redox status and modulating glutathione metabolizing enzymes—An in vitro study. Toxicol. Appl. Pharmacol. 2010, 247, 116–128. [Google Scholar] [CrossRef]
  231. Katiyar, S.K. Silymarin and skin cancer prevention: Anti-inflammatory, antioxidant and immunomodulatory effects (Review). Int. J. Oncol. 2005, 26, 169–176. [Google Scholar] [CrossRef] [PubMed]
  232. Elberry, A.A.; Harraz, F.M.; Ghareib, S.A.; Nagy, A.A.; Gabr, S.A.; Suliaman, M.I.; Abdel-Sattar, E. Antihepatotoxic effect of Marrubium vulgare and Withania somnifera extracts on carbon tetrachloride-induced hepatotoxicity in rats. J. Basic Clin. Pharm. 2010, 1, 247–254. [Google Scholar] [PubMed]
  233. Kuttan, G.; Leemol, D. Immunomodulatory activity of Withania somnifera. J. Ethnopharmacol. 2000, 71, 193–200. [Google Scholar]
  234. Schliebs, R.; Liebmann, A.; Bhattacharya, S.K.; Kumar, A.; Ghosal, S.; Bigl, V. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem. Int. 1997, 30, 181–190. [Google Scholar] [CrossRef]
  235. Mishra, L.C.; Singh, M.D.; Dagenais, B.B. Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): A Review. Altern. Med. Rev. 2000, 5, 334–346. [Google Scholar]
  236. Gohil, K.J.; Patel, J.A.; Gajjar, A.K. Pharmacological review on Centella asiatica: A potential herbal cure-all. Indian J. Pharm. Sci. 2010, 72, 546–556. [Google Scholar] [CrossRef] [PubMed]
  237. Montecchio, G.P.; Samaden, A.; Carbone, S.; Vigotti, M.; Siragusa, S.; Piovella, F. Centella asiatica triterpenic fraction (CATTF) reduces the number of circulating endothelial cells in subjects with post phlebitis syndrome. Haematology 1991, 76, 256–259. [Google Scholar]
  238. Upadhyay, A.K.; Kumar, K.; Kumar, A.; Mishra, H.S. Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi)-validation of the Ayurvedic pharmacology through experimental and clinical studies. Int. J. Ayurveda Res. 2010, 1, 112–121. [Google Scholar] [CrossRef]
  239. Upadhyaya, R.; Sharma, V.; Anita, K.V. Assessment of the multifaceted immunomodulatory potential of the aqueous extract of Tinospora cordifolia. Res. J. Chem. Sci. 2011, 1, 71–79. [Google Scholar]
  240. Singh, R.P.; Banerjee, S.; Kumar, P.V.; Raveesha, K.A.; Rao, A.R. Tinospora cordifolia induces enzymes of carcinogen/drug metabolism and antioxidant system, and inhibits lipid peroxidation in mice. Phytomedicine 2006, 13, 74–84. [Google Scholar] [CrossRef]
  241. Oyedeji, O.A.; Afolayan, A.J. Chemical composition and antibacterial activity of the essential oil of Centella asiatica growing in South Africa. Pharm. Biol. 2005, 43, 249–252. [Google Scholar] [CrossRef]
  242. Ranjith, M.S.; Ranjitsingh, A.J.A.; Gokul Shankar, S.; Vijayalaksmi, G.S.; Deepa, K.; Sidhu, H.S. Enhanced Phagocytosis and Antibody Production by Tinospora cordifolia—A new dimension in Immunomodulation. Afr. J. Biotechnol. 2008, 7, 81–85. [Google Scholar]
  243. Sudhakaran, D.S.; Srirekha, P.; Devasree, L.D.; Premsingh, S.; Michael, R.D. Immunostimulatory effect of Tinospora cordifolia Miers leaf extract in Oreochromis mossambicus. Indian J. Exp. Biol. 2006, 44, 726–732. [Google Scholar] [PubMed]
  244. Nagarkatti, D.S.; Rege, N.N.; Desai, N.K.; Dahanukar, S.A. Modulation of Kupffer cell activity by Tinospora cordifolia in liver damage. J. Postgrad. Med. 1994, 40, 65–67. [Google Scholar] [PubMed]
  245. Rege, N.N.; Bapat, R.D.; Koti, R.; Desai, N.K.; Dahanukar, S. Immunotherapy with Tinospora cordifolia: A new lead in the management of obstructive jaundice. Indian J. Gastroenterol. 1993, 12, 5–8. [Google Scholar]
  246. Premanath, R.; Lakshmidevi, N. Studies on Anti-oxidant activity of Tinospora cordifolia (Miers.) Leaves using in vitro models. Am. J. Sci. 2010, 6, 736–743. [Google Scholar]
  247. Gupta, R.; Sharma, V. Ameliorative effects of Tinospora cordifolia root extract on histopathological and biochemical changes induced by aflatoxin-b (1) in mice kidney. Toxicol. Int. 2011, 18, 94–98. [Google Scholar]
  248. Nagarkar, B.; Kulkarni, R.; Bhondave, P.; Kasote, D.; Kulkarni, O.; Harsulkar, A.; Jagtap, S. Comparative Hepatoprotective Potential of Tinospora cordifolia, Tinospora sinensis and Neem-guduchi. Br. J. Pharm. Res. 2013, 3, 906–916. [Google Scholar] [CrossRef]
  249. Kavitha, B.T.; Shruthi, S.D.; Padmalatha, R.S.; Ramachandra, Y.L. Phytochemical analysis and hepatoprotective properties of Tinospora cordifolia against carbon tetrachloride induced hepatic damage in rats. J. Basic Clin. Pharm. 2011, 2, 139–142. [Google Scholar]
  250. Sharma, V.; Pandey, D. Protective role of Tinospora cordifolia against lead induced hepatotoxicity. Toxicol. Int. 2010, 17, 12–17. [Google Scholar] [CrossRef]
  251. Panchabhai, T.S.; Ambarkhane, S.V.; Joshi, A.S.; Samant, B.D.; Rege, N.N. Protective effect of Tinospora cordifolia, Phyllanthus emblica and their combination against antitubercular drugs induced hepatic damage: An experimental study. Phytother. Res. 2008, 22, 646–650. [Google Scholar] [CrossRef] [PubMed]
  252. Bishayi, B.; Roychowdhury, S.; Ghosh, S.; Sengupta, M. Hepatoprotective and immunomodulatory properties of Tinospora cordifolia in CCl4 intoxicated mature albino rats. J. Toxicol. Sci. 2002, 27, 139–146. [Google Scholar] [CrossRef] [PubMed]
  253. Chougale, A.D.; Ghadyale, V.A.; Panaskar, S.N.; Arvindekar, A.U. Alpha glucosidase inhibition by stem extract of Tinospora cordifolia. J. Enzym. Inhib. Med. Chem. 2009, 24, 998–1001. [Google Scholar] [CrossRef]
  254. Rajalakshmi, M.; Eliza, J.; Priya, C.E.; Nirmala, A.; Daisy, P. Anti-diabetic properties of Tinospora cordifolia stem extracts on streptozotocin-induced diabetic rats. Afr. J. Pharm. Pharmacol. 2009, 3, 171–180. [Google Scholar]
  255. Latif, M.; Iqbal, L.; Fatima, N. Evaluation of antioxidant & urease inhibition activity of roots of Glycyrrhiza glabra. Pak. J. Pharm. Sci. 2012, 25, 99–102. [Google Scholar]
  256. Tohma, H.S.; Gulcin, I. Antioxidant and radical scavenging activity of aerial parts and roots of Turkish Liquorice (Glycyrrhiza glabra). Int. J. Food Prop. 2010, 13, 657–671. [Google Scholar] [CrossRef]
  257. Chin, Y.W.; Jung, H.A.; Liu, Y.; Su, B.N.; Castoro, J.A.; Keller, W.J.; Pereira, M.A.; Kinghorn, D. Anti-oxidant constituents of the roots and stolons of Licorice (Glycyrrhiza glabra). J. Agric. Food Chem. 2007, 55, 4691–4697. [Google Scholar] [CrossRef]
  258. Mazumdar, P.M.; Patnayak, S.P.; Parwani, H. Evaluation of immunomodulatory activity of Glycyrrhiza glabra roots in combination with zinc. Asian Pac. J. Trop. Med. 2012, 2, S15–S20. [Google Scholar] [CrossRef]
  259. Al-Razzuqii, R.A.M.; Al-Hussaini, J.A. Hepatoprotective effect of Glycyrrhiza glabra in CCl4 induced model in acute liver injury. J. Physiol. Pharmacol. 2012, 2, 259–263. [Google Scholar]
  260. Sitohy, M.Z.; El-Massry, R.A.; El-Saadany, S.S.; Labib, S.M. Metabolic effect of licorice roots (Glycyrrhiza Glabra) on lipid distribution pattern, liver and renal functions of albino rats. Nahrung 1991, 35, 799–806. [Google Scholar] [CrossRef]
  261. Kaur, R.; Kaur, H.; Dhindsa, A.S. Glycyrrhiza Glabra: A phytopharmacological review. Int. J. Pharm. Sci. Res. 2013, 4, 2470–2477. [Google Scholar]
  262. Sakhare, P.; Harne, S.; Kalorey, D.; Warke, S.; Bhandarkar, A.; Kurkure, N. Effect of Polyherbal Feed Supplement “Growell” during Induced Aflatoxicosis, Ochratoxicosis and Combined Mycotoxicoses in Broiler. Vet. Arch. 2007, 77, 129–146. [Google Scholar]
  263. Kalorey, D.R.; Kurkure, N.V.; Ramgaonkar, I.S.; Sakhare, P.S.; Warke, S.; Nigot, N.K. Effect of polyherbal feed supplement “growell” during induced aflatoxicosis, ochratoxicosis and combined mycotoxicoses in broilers. Asian-Aust. J. Anim. Sci. 2005, 18, 375–383. [Google Scholar] [CrossRef]
  264. Muhammad, S.A.; Abubakar, A.L.; Rabiu, S.; Sulaiman, I. Antioxidant content and in vitro 2,2-diphenyl-1-picrylhydrazyl free radical scavenging activity of selected medicinal plants. J. Intercult. Ethnopharmacol. 2018, 7, 57–65. [Google Scholar]
  265. Amminikutty, N.; Spalenza, V.; Jarriyawattanachaikul, W.; Badino, P.; Capucchio, M.T.; Colombino, E.; Schiavone, A.; Greco, D.; D’Ascanio, V.; Avantaggiato, G.; et al. Turmeric Powder Counteracts Oxidative Stress and Reduces AFB1 Content in the Liver of Broilers Exposed to the EU Maximum Levels of the Mycotoxin. Toxins 2023, 15, 687. [Google Scholar] [CrossRef] [PubMed]
  266. Kim, M.; Shukla, S.; Oh, Y.; Chung, S.H.; Kim, M. Comparative diminution of patulin content in apple juice with food-grade additives sodium bicarbonate, vinegar, mixture of sodium bicarbonate and vinegar, citric acid, baking powder, and ultraviolet irradiation. Front. Pharmacol. 2018, 9, 822. [Google Scholar] [CrossRef]
  267. Meizhen, Y.U.; Ping, L.I.U. Discussion on emergency management of food safety from the perspective of foodborne diseases caused by mycotoxins. LWT—Food Sci. Technol. 2023, 43, e114622. [Google Scholar] [CrossRef]
  268. Yun, H.; Lim, S.; Jo, C.; Chung, J.; Kim, S.; Kwon, J.H.; Kim, D. Effects of organic acids, amino acids and ethanol on the radio-degradation of patulin in an aqueous model system. Radiat. Phys. Chem. 2008, 77, 830–834. [Google Scholar] [CrossRef]
  269. Drusch, S.; Kopka, S.; Kaeding, J. Stability of patulin in a juice-like aqueous model system in the presence of ascorbic acid. Food Chem. 2007, 100, 192–197. [Google Scholar] [CrossRef]
  270. Fremy, J.M.; Castegnaro, M.J.; Gleizes, E.; De Meo, M.; Laget, M. Procedures for destruction of patulin in laboratory wastes. Food Addit. Contam. 1995, 12, 331–336. [Google Scholar] [CrossRef]
  271. Haazele, F.M.; Guenter, W.; Marquardt, R.R.; Frohlich, A.A. Benefical effects of dietary ascorbic acid supplement on hens subjected to ochratoxin A toxicosis under normal and high ambient temperatures. Can. J. Anim. Sci. 1993, 73, 149–157. [Google Scholar] [CrossRef]
  272. Haazele, F.M. Response to Dietary Ascorbic Acid Supplementation in Laying Hens: Effects of Exposure to High Temperature and Ochratoxin Ingestion. Ph.D. Thesis, University of Manitoba, Winnipeg, MB, Canada, 1992. [Google Scholar]
  273. Zhang, Q.; Chen, W.; Zhang, B.; Zhang, Y.; Xiao, Y.; An, Y.; Han, L.; Deng, H.; Yao, S.; Wang, H.; et al. Lonp1 and Sig-1R contribute to the counteraction of ursolic acid against ochratoxin A-induced mitochondrial apoptosis. Food. Chem. Toxicol. 2023, 172, 113592. [Google Scholar] [CrossRef]
  274. Li, C.; Chen, W.; Zheng, L.; Zhang, B.; Yang, X.; Zhang, Q.; Wang, N.; Wang, Y.; Yang, J.; Sha, J.; et al. Ameliorative effect of ursolic acid on ochratoxin A-induced renal cytotoxicity mediated by Lonp1/Aco2/Hsp75. Toxicon 2019, 168, 141–146. [Google Scholar] [CrossRef]
  275. Zhang, Q.; Chen, W.; Zhang, B.; Li, C.; Zhang, X.; Wang, Q.; Wang, Y.; Zhou, Q.; Li, X.; Shen, X.L. Central role of TRAP1 in the ameliorative effect of oleanolic acid on the mitochondrial-mediated and endoplasmic reticulum stress-excitated apoptosis induced by ochratoxin A. Toxicology 2021, 450, 152681. [Google Scholar] [CrossRef]
  276. Rahimtula, A.D.; Bereziat, J.C.; Bussacchini-Griot, V.; Bartsch, H. Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem. Pharmacol. 1988, 37, 4469–4477. [Google Scholar] [CrossRef]
  277. Orrenius, S.; Bellomo, G. Toxicological implications of perturbation of Ca2+ homeostasis in hepatocytes. In Calcium and Cell Function; Cheung, W.Y., Ed.; Academic Press: Orlando, FL, USA, 1986; p. 185. [Google Scholar]
  278. El-Adawi, H.; El-Azhary, D.; Abd El-Wahab, A.; El-Shafeey, M.; Abdel-Mohsen, M. Protective effect of milk thistle and grape seed extracts on fumonisin B1 induced hepato- and nephrotoxicity in rats. J. Med. Plant Res. 2011, 5, 6316–6327. [Google Scholar] [CrossRef]
  279. Pradhan, S.C.; Girish, C. Hepatoprotective herbal drug, Silymarin from experimental pharmacology to clinical medicine. Indian J. Med. Res. 2006, 124, 491–504. [Google Scholar] [PubMed]
  280. Shaker, E.; Mahmoud, H.; Mnaa, S. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage. Food Chem. Toxicol. 2010, 48, 803–806. [Google Scholar] [CrossRef] [PubMed]
  281. Abenavoli, L.; Aviello, G.; Capasso, R.; Milic, N.; Capasso, F. Milk thistle for treatment of nonalcoholic fatty liver disease. Hepat. Mon. 2011, 11, 173–177. [Google Scholar]
  282. Karimi, G.; Vahabzadeh, M.; Lari, P.; Rashedinia, M.; Moshiri, M. Silymarin, a promising pharmacological agent for treatment of diseases. Iran. J. Basic Med. Sci. 2011, 14, 308–317. [Google Scholar]
  283. Bahmani, M.; Shirzad, H.; Rafieian, S.; Rafieian-Kopaei, M. Silybum marianum: Beyond Hepatoprotection. J. Evid.-Based Complem. Altern. Med. 2015, 20, 292–301. [Google Scholar] [CrossRef] [PubMed]
  284. Dietrich, D.R.; Heussner, A.H.; O’Brien, E. Ochratoxin A: Comparative pharmacokinetics and toxicological implications (experimental and domestic animals and humans). Food Addit. Contam. 2005, 22, 45–52. [Google Scholar] [CrossRef] [PubMed]
  285. Ludovico, A.; Capasso, R.; Milic, N.; Capasso, F. Milk thistle in liver diseases: Past, present, future. Phytother. Res. 2010, 24, 1423–1432. [Google Scholar]
  286. Benkerroum, N. Chronic and acute toxicities of aflatoxins: Mechanisms of action. Int. J. Environ. Res. Public Health 2020, 17, 423. [Google Scholar] [CrossRef]
  287. Rawal, A.; Muddeshwar, M.; Biswas, S. Effect of rubia cordifolia, Fagonia cretica Linn, and Tinospora cordifolia on free radical generation and lipid peroxidation during oxygen-glucose deprivation in rat hippocampal slices. Biochem. Biophys. Res. Commun. 2004, 324, 588–596. [Google Scholar] [CrossRef]
  288. Sangeetha, M.K.; Balaji, R.H.R.; Gayathri, V.; Vasanthi, H.R. Tinospora cordifolia attenuates oxidative stress and distorted carbohydrate metabolism in experimentally induced type 2 diabetes in rats. Nat. Med. 2011, 65, 544–550. [Google Scholar] [CrossRef]
  289. Agarwal, P.; Karamalakova, Y.; Adhikari, M.; Gupta, D.; Nikolova, G.; Hadzhibozheva, P.; Gadjeva, V.; Stoev, S.; Arora, R.; Zheleva, A. Investigations on DPPH scavenging capacity before and after UV-irradiation of aqueous root extract of Glycyrrhiza glabra. J. BioSci. Biotechnol. 2015, SE/ONLINE, 183–188. [Google Scholar]
  290. Sinha, K.; Mishra, N.P.; Singh, J.; Khanuja, S.P.S. Tinospora cordifolia (Guduchi), a reservoir plant for therapeutic applications: A Review. Indian J. Tradit. Knowl. 2004, 3, 257–270. [Google Scholar]
  291. Atal, C.K.; Sharma, M.L.; Kaul, A.; Khajuria, A. Immunomodulating agents of plant origin. I: Preliminary screening. J. Ethnopharmacol. 1986, 18, 133–141. [Google Scholar] [CrossRef]
  292. Sorrenti, V.; Di Giacomo, C.; Acquaviva, R.; Barbagallo, I.; Bognanno, M.; Galvano, F. Toxicity of Ochratoxin A and Its Modulation by Antioxidants: A Review. Toxins 2013, 5, 1742–1766. [Google Scholar] [CrossRef]
  293. Stoev, S.D. Long term preliminary studies on toxic and carcinogenic effect of individual or simultaneous exposure to ochratoxin A and penicillic acid in mice. Toxicon 2020, 184, 192–201. [Google Scholar] [CrossRef] [PubMed]
  294. Ezealigo, U.S.; Joshua, P.E.; Ononiwu, C.P.; Agbo, M.O.; Asomadu, R.O.; Ogugua, V.N. Total phenolic and flavonoid content and in vitro antioxidant activity of methanol extract and solvent fractions of Desmodium Ramosissimum G. Don. Med. Sci. Forum 2021, 2, 15. [Google Scholar] [CrossRef]
  295. Rastegar, H.; Shoeibi, S.; Yazdanpanah, H.; Amirahmadi, M.; Khaneghah, A.M.; Campagnollo, F.B.; Sant’Ana, A.S. Removal of aflatoxin B1 by roasting with lemon juice and/or citric acid in contaminated pistachio nuts. Food Control 2017, 71, 279–284. [Google Scholar] [CrossRef]
  296. Mamo, F.T.; Abate, B.A.; Tesfaye, K.; Nie, C.; Wang, G.; Liu, Y. Mycotoxins in Ethiopia: A review on prevalence, economic and health impacts. Toxins 2020, 12, 648. [Google Scholar] [CrossRef]
  297. Abbas, H.K.; Accinelli, C.; Shier, W.T. Biological control of aflatoxin contamination in US crops and the use of bioplastic formulations of Aspergillus flavus biocontrol strains to optimize application strategies. J. Agric. Food Chem. 2017, 65, 7081–7087. [Google Scholar] [PubMed]
  298. Diao, E.; Ren, D.; Liu, T.; Zhang, J.; Hu, W.; Hou, H. Ozone detoxification of patulin in aqueous solution and cytotoxic evaluation using human hepatic carcinoma cells. Toxicon 2018, 155, 21–26. [Google Scholar]
  299. Nurul Adilah, Z.; Mohd Redzwan, S. Effect of dietary macronutrients on aflatoxicosis: A mini-review. J. Sci. Food Agric. 2017, 97, 2277–2281. [Google Scholar] [PubMed]
  300. Sreemannarayana, O.; Frohlich, A.A.; Vitti, T.G.; Marquardt, R.R.; Abramson, D. Studies of the tolerance and disposition of ochratoxin A in young calves. J. Anim. Sci. 1988, 66, 1703–1711. [Google Scholar] [CrossRef]
  301. Creppy, E.E.; Lugnier, A.A.J.; Fasiolo, F.; Heller, K.; Roschenthaler, R.; Dirheimer, G. In vitro inhibition of yeast phenylalanyl-tRNA synthetase by ochratoxin A. Chem. Biol. Interact. 1979, 24, 257–261. [Google Scholar]
Table 1. Natural protection by biodegradation, biotransformation, or binding of mycotoxins by target microorganisms, yeasts, fungi, or enzymes.
Table 1. Natural protection by biodegradation, biotransformation, or binding of mycotoxins by target microorganisms, yeasts, fungi, or enzymes.
Biodegradation or Binding by Microorganisms, Yeasts, Fungi, or EnzymesDegradation/Detoxification or Binding MycotoxinsReference
Microorganisms
Lactobacillus rhamnosusAFs binding capability[46,47]
Lactobacillus plantarumPAT degradation capacity to hydroascladiol[48]
Lactobacillus acidophilusPAT and OTA degradation capacity [49]
L. sanfrancisco, L. plantarum, L. brevis, Saccharomyces cerevisiae yeast strainOTA degradation capacity (around 50–54%)[50,51]
L. brevis, L. plantarum, Oenococcus oeni, Leuconostoc mesenteroides, Pediococcus acidilactici identified from wine or grape mustOTA degradation capacity [52]
Bifidobacterium bifidum, B. breve, Lactobacillus delbrueckii bulgaricus, L. casei, L. paracasei, L. johnsonii, L. rhamnosus, L. plantarum, L. salivariusOTA degradation capacity (around 30–97%) to non-toxic compound OTα[53]
Lactic acid bacteria (LAB)PAT removing capacity[54]
Alicyclobacillus spp.PAT degradation capacity in juice[55]
Actinobacterial strains, e.g., Streptomyces AT8, AT10, SN7, G10, PT1OTA degradation capacity (between 22% and 52%) and/or adsorption capacity (between 16% and 33%)[56]
Flavobacterium aurantiacumAFs removing capacity[57]
Lactobacillus kefiri,Acetobacter syzygiiOTA, AFB1 and ZEA degradation capacity[58]
Oenococcus oeni identified from wineOTA degradation capacity[59]
Gluconobacter oxydansPAT degradation capacity to Z-ascladiol and E-ascladiol in juice from apples[60]
Eubacterium BBSH 797 strainDON degradation capacity to the non-toxic de-epoxy-DON[61]
Bacillus licheniformisCM21,Sl-1OTA degradation capacity (35–98%)[62,63]
Bacillus licheniformisAFB1 degradation capacity (around 74%)[63]
BacillussubtilisAFB1 degradation capacity (around 85%)[63]
Pediococcus parvulus UTAD 473OTA degradation capacity (80–90%) to non-toxic compound OTα[64]
Acinetobacter calcoaceticus str. OTA degradation capacity to non-toxic compound OTα[65,66]
Bacillus amyloliquefaciens ASAG1OTA degradation capacity (about 98%) to non-toxic compound OTα[67]
Brevibacterium casei, B. epidermidis, B. iodinum, B. linensOTA degradation capacity (100%) to non-toxic compound OTα[68]
Bacillus subtilis CW 14OTA degradation capacity (up to 97%)[69]
Stenotrophomonas nitritreducens, Eubacterium callanderi, Sphingomonas paucimobilis, S. asaccharolyticaOTA degradation capacity (between 95% and 100%) to non-toxic compound OTα[70]
Eubacterium biforme MM11 identified from intestinal content of swineOTA and AFB1 degradation capacity (between 77% and 100%)[71]
Cupriavidus basilensis ŐR16 str. identified from soilOTA degradation capacity (100%) to non-toxic compound OTα[72]
Luteimonas sp. CW574, Silanimonas sp. CW282, Stenotrophomonas sp. CW117, Pseudomonas aeruginosa N17-1, Lysobacter sp. CW239 OTA degradation capacity[39]
Yeasts and Fungi
Trichosporon mycotoxinivorans yeast strain OTA and ZEA detoxification capacity [73]
Trichosporon mycotoxinivorans yeast strainZEA degradation capacity to non-toxic compound ZOM-1[74]
Trichosporon mycotoxinivorans yeast str. and Eubacterium BBSH 797DON, ZEA and OTA in vivo degradation capacity [61,75,76]
Komagataella pastoris yeast strainFUMs detoxification capacity [77]
Yeast strains Metschnikowia pulcherrima M320, MACH1; Pichia guilliermondii M8, M29; Rhodococcus erythropolis AR14; Kloeckera lindneri GAL5 OTA degradation capacity (between 26% and 84%)[78]
Phaffia rhodozyma yeast strain CBS 5905OTA degradation capacity (around 90%) to non-toxic compound OTα, and OTA adsorption capacity (around 23%)[79]
Kluyveromyces marxianus yeast strain C2, identified from intestinal content of pigsOTA degradation capacity (82–83%)[39]
Yarrowia lipolytica yeast strainOTA degradation capacity (around 88%)[80]
Trichosporon yeast strains DSM 14162, DSM 14156, DSM 14153, 178; Trichosporon mycotoxinivorans MTV, 115; Cryptococcus 118; Rhodotorula sp. DSM 14155, 124 OTA degradation capacity (between 80 and 100%) to non-toxic compound OTα[70,73,81]
Saccharomyces cerevisiae yeast strainAFs binding capability[82]
Saccharomyces cerevisiaeyeast strainPAT degradation capacity to Z-ascladiol and E-ascladiol [83]
Yeast strains Schizosaccharomyces pombe, Kloeckera apiculata, Saccharomyces cerevisiae, Candida pulcherima, Candida intermedia, Candida friedrichii, Cyberlindnera jadinii, Torulaspora delbrueckii, Lachancea thermotoleransOTA degradation capacity (between 25% and 84%) to non-toxic compound OTα [84,85,86,87]
Rhodosporidium paludigenum yeast strainPAT degradation capacity to less toxic compound desoxypatulinic acid[88]
Rhodosporidium kratochvilovae strain LS11 and Sporobolomyces sp. yeast strain IAM 13481PAT degradation capacity to less toxic metabolites, e.g., desoxypatulinic acid and ascladiol[89,90]
Yarrowia lipolytica yeast strain Y-2,Brevundimonas vermicularis B-1OTA degradation capacity (between 84% and 87%)[91]
Phoma sp., Mucor sp., Rhizopus spp. 663, 668 and 710, Trichoderma sp. 639, Trichoderma harzianum, Bacillus subtilis, Alternaria sp. and some Sporotrichum strainsAFs degradation capacity is around 65–99%[92,93,94,95]
Oyster mushroom Pleurotus ostreatusOTA detoxification capacity[45]
Byssochlamys nivea str. FF1-2PAT degradation capacity[96]
Aspergillus. Japonicus AX35, A. carbonarius SA332, A. niger GX312OTA degradation capacity (between 83% and 99%) to non-toxic compound OTα[97]
A. niger M00120OTA degradation capacity (up to 99%) to non-toxic compound OTα[98]
A. tubingensis M074, M036OTA degradation capacity (up to 95%) to non-toxic metabolite OTα[99]
A. wentii, A. carbonarius, A. niger, A. Japonicus, A. ochraceus, A. fumigatus, A. clavatus, A. versicolor, Cladosporium sp., P. spinulosum, P. aurantiogriseum, Botrytis cinerea, identified from grapesOTA degradation capacity (up to 80%) to non-toxic metabolite OTα[100,101,102]
Rhizopus microsporus, R. stolonifer, R. oryzae, R. homothallicusOTA degradation capacity (up to 96.5%) to non-toxic compound OTα[103]
Aureobasidium pullulans AU34-2, AU18-3B, AU14-3-1, LS30OTA degradation capacity (between 75 and 90%) to non-toxic compound OTα[104]
Pleurotus ostreatusOTA degradation capacity (up to 77%) to non-toxic compound OTα[105]
Candida guilliermondiiPAT degradation capacity[106]
Candida guilliermondii, Candida lusitaniae, Candida famata, Kloeckera spp., Cryptococcus laurentii, Rhodotorula glutinis identified from Turkish grapes for wineOTA degradation capacity[107]
Enzymes
Carboxypeptidase Y originating from Saccharomyces cerevisiaeOTA degradation capacity to non-toxic compound OTα[108]
Carboxypeptidase A originating from bovine pancreas OTA degradation capacity to non-toxic compound OTα[109,110,111]
Carboxypeptidase originating from Bacillus amyloliquefaciens, Acinetobacter sp. neg1, Phaffia rhodozyma, OTA degradation capacity to non-toxic compound OTα[67,79,112]
Hydrolase originating from A. nigerOTA degradation capacity to non-toxic compound OTα[113]
Lipase A originating from A. nigerOTA degradation capacity to non-toxic compound OTα[114]
A crude metalloenzyme originating from A. nigerOTA hydrolyzation capacity[115]
A crude enzyme AncexOTA degradation capacity[109]
Protease A originating from A. nigerOTA degradation capacity to non-toxic compound OTα[109]
CotA laccase originating from Bacillus licheniformis ZOM-1AFs, ZEA, and AOH degradation capacity[116]
Enzymes glucose oxidase and/or peroxidaseAlternaria mycotoxin AOH degradation capacity in fruits[116,117]
Enzymes polyphenol oxidase and/or peroxidasePAT degradation capacity in fruits[118]
Table 2. Microorganisms, yeasts, fungi, or bioactive natural substances effective against target mycotoxin-producing fungi.
Table 2. Microorganisms, yeasts, fungi, or bioactive natural substances effective against target mycotoxin-producing fungi.
Microorganisms, Yeasts, Fungi, or Bioactive Natural Substances Effective Against Target Mycotoxin-Producing FungiInhibition or Suppression of Fungal Development/Growth and Subsequent Mycotoxin Production of Following FungiReference
Microorganisms
Bacillus subtilis strainsInhibition of fungal development of Fusarium strains and following production of FUMs.[34]
Bacillus spp., e.g., B. subtilis, B. megaterium, B. mojavensis, B. amyloliquefaciens, B. mycoides, B. pumilus, B. cereus, and B. mojavensis Reported as good biocontrol agents against AFs contamination.[147,148,149,150,151]
Bacillus megateriumReported to prevent nearly 100% of AFs production in broth medium. [148]
Bacillus subtilisReported to control the development of Aspergillus parasiticus (nearly 92%) and subsequent AFs production by up to 100%. [149]
Apple dip treatment with suspension of microorganisms Bacillus subtilis or Pseudomonas fluorescens Inhibition of fungal development of P. expansum at the time of cold storage and following PAT production in apples.[170,171]
Fermented cell-free supernatants of Paenibacillus chibensis CECT 375, Bacillus amyloliquefaciens CECT 493, and Pantoea agglomerans CECT 850.In vitro antifungal activities against OTA- and AFs-producing fungi due to high content of acetic acid, lactic acid, phenyllactic acid, and benzoic acid.[172]
Actinobacterial strains, e.g., Streptomyces G10, ML5, and MS1 Inhibition of expression of target genes responsible for biosynthesis of OTA by A. carbonarius. [56]
Lactobacillus plantarumInhibition of fungal development of P. expansum and A. parasiticus, and following production of PAT and AFs.[135]
Lactobacillus (LAB), e.g., L. delbrueckii, L. plantarum, L. reuteri, L. acidophilus, L. rhamnosus, L. paraplantarum, L. fermentum, L. casei and L. pentosus Reported to be effective towards AFs, but L. plantarum was found to be the most effective against AFs production. [173,174,175]
Lactobacillus plantarum B4496, Lactobacillus brevis 207 and Lactobacillus sanfranciscensis BB12 isolated from fermenting cocoaReported to have good in vitro antifungal activities against OTA-producing fungi A. niger, A. Carbonarius, and A. ochraceus, with capabilities ranging from 15% to 67%.[176]
Pseudomonas fluorescensSuppresses the conidia germination of A. flavus by nearly 20%, in addition to the inhibition of AFB1 production (above 99%) in peanut medium. [177,178]
Pseudomonas chlororaphis isolated from maizeReported to inhibit the development of A. flavus by nearly 100%.[152]
Pseudomonas protegens strain AS15 isolated from rice grainsSuppress up to 83% of AFs production, in addition to the suppression of the development of A. flavus (up to 68%). [179]
Pseudomonas syringaeInhibition of postharvest fungal development of P. expansum and Botrytis cinerea (gray mold and blue mold) on apples and following PAT production.[131]
Streptomyces strains, e.g., S. anulatus, S. yanglinensis, S. roseolus, and S. alboflavusFound to be very effective against aflatoxigenic fungi such as Aspergillus flavus.[153,154,155]
Bacteria Serratia marcescens strain JPP1 isolated from peanut shellsSuppress AFs production by nearly 98%, and subsequent development of A. parasiticus by nearly 95%.[180]
Bacteria Nannocystis exedensFound to suppress significantly the growth of A. flavus and A. parasiticus.[156]
Fungi and Yeasts
Ascomycota yeast species (Candida guilliermondii P3 and Pichia ohmeri 158) Inhibition of fungal development of Penicillium expansum and following PAT production. [181]
Non-toxigenic strains, e.g., Aspergillus flavus Displacement of mycotoxigenic strains by biocompetition and subsequent decrease in AFs levels in the feedstuffs or foods. [140,141,182]
Non-toxigenic strains of Aspergillus flavus AF36Displacement of mycotoxigenic strains by biocompetition and subsequent decrease of AFs production in cotton and peanut between 70% and 90%. [146]
Non-toxigenic A. flavus strain NRRL21882 and A. parasiticus strain NRRL21369, and commercially available biopesticide Afla-guard (A. flavus strain NRRL21882).Reported to be very effective biocontrol agents against AFs contamination in peanuts when applied in field conditions at preharvest time or in postharvest storage.[183]
Non-toxigenic A. parasiticus applied in the fieldDecreases AFs contamination during storage time.[161]
Atoxigenic strain BN30Reported as very effective in preventing AFs contamination of maize in Africa.[184]
A. flavus strains AF051Reported as very effective in decreasing AFs contamination in peanut fields in China by up to 99%.[185]
Atoxigenic CT3 and K49 strainsReported to decrease AFs contamination of maize by up to 65–94% in a four-year study[145]
Atoxigenic AR100G, AR27, and AFCHG2 strains of A. flavusReported to decrease AFs contamination in groundnut fields in Argentina.[186]
Atoxigenic Aspergillus niger strain FS10Reported to decrease AFs production in the field.[187,188]
Atoxigenic Penicillium chrysogenum strain RP42CSuppresses the growth of toxigenic Aspergillus strains.[189]
Yeast strains: Kluyveromyces spp., Debaryomyces hansenii strain BCS003, Candida maltose, Pichia anomala, Saccharomyces cerevisiae RC016, and Saccharomyces cerevisiae RC008Suppress the growth of toxigenic Aspergillus strains and subsequent AFs production[147]
Trichoderma spp.: T. viridae, T. harzianum, T. Auroviride, and T. longibrachiatumReported to be very effective against AFs production in the field at a rate between 50% and 80%. [147,190]
Trichoderma spp.Reported to be very effective against AFs contamination in sweet corn and groundnut by 65% and 57%, respectively.[157]
Rhodotorula glutinis LS11Inhibition of fungal development of P. expansum and following PAT production.[90]
Pichia ohmeri 158Inhibition of fungal development of P. expansum and following PAT production.[191]
Pichia caribbica yeast Inhibition of blue mold rot and following production of PAT in apples.[192]
Pantoea agglomerans CPA-1 and Candida sake CPA-2 Inhibition of fungal development of P. expansum and following PAT production.[193]
Torulaspora delbrueckii and Candida membranifaciensInhibition of fungal development of P. expansum and following PAT production.[194,195]
Saccharomycopsis schoenii predacious yeast Suppression and biological control of fungal development of P. expansum, P. Digitatum, and P. italicum by true predation. [196]
Bioactive natural substances
Vanillic acidInhibition of fungal development of Aspergillus species and following OTA production. [197]
Polyphenols, flavonoids, silymarin, and carotenoidsInhibition of fungal development of A. flavus and following AFs production.[198,199,200]
Target essential oils, e.g., clove oil and cinnamon Lowering PAT content in apples.[201]
Natural extracts of orange peel, cistus, and eucalyptus extract in a grape-based medium at concentrations of 10 and 20 mg/mLNatural extracts of orange peel and cistus were found to have a good antifungal activity against the toxigenic Aspergillus carbonarius strain, whereas eucalyptus extract was reported to reduce OTA production by up to 85% at concentration 10 mg/mL with slight influence on fungal growth.[202]
Plant extracts of target essential oils, e.g., oregano (Origanum vulgare subsp. hirtum), lavender (Lavandula stoechas), spearmint (Mentha spicata), and sage (Salvia Fruticosa), as well as some monoterpenoids, e.g., enchone, carvone, carvacrol, 1,8-cineole, terpinen-4-ol, and α-pinene Inhibition of fungal development of Fusarium oxysporum, P. expansum, A. terreus, Verticillium dahliae, and mycotoxin production by the same species.[203]
Lyophilized filtrates of Lentinula edodes Stimulated production of antioxidant enzymes (e.g., glutathione peroxidase, superoxide dismutase, and catalase,) by A. parasiticus and inhibited AFs production by the same species.[204]
Garlic vapor or extract exposure of applesInhibition of fungal development of P. expansum and following PAT production.[205]
Table 3. Herbs, plants, vitamins, and natural bio-substances having good protective possibilities against the harmful effects of mycotoxins, which could be used as feed supplements.
Table 3. Herbs, plants, vitamins, and natural bio-substances having good protective possibilities against the harmful effects of mycotoxins, which could be used as feed supplements.
Herbs/Plants, Vitamins, or Natural Bio-Substances Protective Properties Against Mycotoxins in Experimental Animals or Poultry Reference
Herbs and Plants
Roxazyme-G (polyenzyme complement synthesized by “Trichoderma” fungi) given at 200 ppm to chicken feeds-Increases OTA-induced suppression of body weight gain
-Increases OTA-induced decrease in egg production
-Decrease OTA-induced rise in serum levels of urea, creatinine, and glucose
-Protection against OTA-induced kidney and liver damages
-Protection against OTA-induced suppression of humoral immune response
-Protection against OTA-induced damages in lymphoid organs, e.g., spleen, bursa of Fabricius, and thymus
[6,209]
Rosallsat (a plant extract of bulbus Allii Sativi and seminum Rosae caninae), at dose 0.6 mL/kg b.w. per day, given to chicken feeds-Decreases OTA content in kidneys and liver
-Suppresses OTA-induced lipid peroxidation
-Protection against OTA-provoked kidney and liver damages
-Protection against OTA-provoked damages in lymphoid organs, e.g., spleen, bursa of Fabricius, and thymus
[210]
5% total water extract of Cynara scolymus L (Artichoke) prepared as steam infusion and given to chicks in levels of 5 mL/kg.b.w. via feeds or drinking water-Increases hepatobiliary excretion of OTA
-Improves diuresis and increases urinary excretion of OTA
-Decreases OTA content in kidneys and liver
-Improves OTA-induced suppression of body weight gain
-Increases OTA-induced decrease in egg production
-Protection against OTA-provoked liver and kidney damages
-Protection against OTA-provoked damages in lymphoid organs, e.g., spleen, bursa of Fabricius, and thymus
-Anti-permeability and vasoconstrictive effects towards OTA-provoked edematous changes
-Decreases OTA-induced rise in serum levels of urea, creatinine, uric acid, and glucose
-Protection against OTA-induced suppression of humoral immune response
[6,17,208,209,210]
Sesame seed given at level 80,000 ppm to chicken feed-Improves OTA-induced suppression of body weight gain
-Increases OTA-induced decrease in eggs production
-Improves OTA-inhibited protein synthesis
-Protection against OTA-provoked kidney and liver damages
-Protection against OTA-provoked damages in lymphoid organs, e.g., spleen, bursa of Fabricius, and thymus
-Decreases OTA-induced rise in serum urea and creatinine
-Protection against OTA-induced suppression of humoral immune response
[6,209]
Silybum marianum given at levels of 1100 ppm to chicken feeds
or Silymarin introduced at 1% to chicken diet
-Protection against OTA-provoked liver and kidney damages
-Protection against OTA-provoked damages in lymphoid organs, e.g., spleen, bursa of Fabricius, and thymus
-Decrease OTA-induced rise in serum levels of uric acid
-Decrease OTA-induced rise in serum enzyme levels of AST and ALT
-Protection against OTA-provoked suppression in humoral immune response
[211,213]
Silymarin given at 10,000 ppm to chicken feedsAmeliorates the immunotoxic effects induced by 1 ppm OTA[218]
Silybum marianum given at levels of 10,000 ppm to chicken feeds
or Silymarin at 600 mg/kg b.w.
-Improve AFs-induced suppression of body weight gain
-Decreases AFs-induced rise in serum enzyme levels of ALT, AST and ALP
-Protection against AFs-provoked liver damages
-Improves feed conversion ratio in AFs-treated chicks
[219,220]
Silymarin given orally to rats at dose 200 mg/kg b.w. daily-Protection against AFs-provoked diabetic nephropathy
-Increases the renal activity of antioxidant enzymes
[221]
S. marianum extract given to rats at 600 mg/kg b.w. or Silymarin given to rats at 50 mg/kg b.w. or dogs at 20 mg/kg b.w.-Protection against experimental damages in kidneys
-Protection against the increase in lipid peroxidation
-Protective effect against the increase in serum creatinine and urea
[222,223]
Silybum marianum given at various levels or Silymarin given to rats at dose 50–200 mg/kg b.w. per day -Protection against experimental damages in liver
-Protection against the increased serum levels of ALT, AST, ALP, γ-GT, and LDH
-Suppresses lipid peroxidation in rats/mice
-Protection against oxidative stress
-Protection against carcinogenicity of various chemical agents
[224,225,226,227,228]
Silybum marianum or Silymarin studied in in vivo or in vitro studies-Protection against humoral and cellular immunity
-Antioxidative effect against oxidative stress
-Protective effects against chemical carcinogenesis
[229,230,231]
Withania somnifera extract given at dose 500 mg/kg/day or Silymarin given at dose 150 mg/kg/day to rats-Protective effect against liver damages
-Suppressive effect on lipid peroxidation
-Decreases serum enzyme levels of AST, ALT, and LDH
-Antioxidative effect against oxidative stress
[232]
Withania somnifera given at levels of 4000 ppm to chicken feeds-Protection against OTA-induced liver damages
-Protection against OTA-provoked damages in lymphoid organs
-Protection against OTA-induced suppression on humoral immune response
-Decreases OTA-induced rise in serum enzyme levels of ALT and AST
[211]
Withania somnifera extract at dose 20 mg (dose per mouse i.p.) -Protection of humoral and cellular immunity
-Antioxidative properties
[233]
Withania somnifera extract given at dose 40 mg/kg b.w.-Protection against brain damages[234]
Withania somnifera given at various feed levels-Improves body weight gain
-Immunomodulatory properties
-Antioxidative properties
-Anti-neoplastic properties
-Anti-inflammatory properties
[235]
Centella asiatica at different doses in different animals-Protection of skin, vascular intima and gastrointestinal mucosa
-Protection against oxidative stress
-Antibacterial properties
[236,237]
Centella asiatica given at levels of 4600 ppm to chicken feeds-Slight protective properties against OTA-induced suppression of humoral immunity
-A slight protection against OTA-provoked damages in lymphoid organs
-Decreases OTA-induced rise in serum enzyme activity of AST
[211]
Tinospora cordifolia extracts at different doses in different animals-Antioxidative, anti-neoplastic, hepatoprotective, antidiabetic, and anti-inflammatory properties
-Immunomodulatory properties
-Suppression of lipid peroxidation
-Diuretic properties
[238,239,240]
Centella asiatica essential oil-Immunostimulating properties
-Protection towards kidney and liver damages
-Antibacterial properties
[241]
Tinospora cordifolia given at levels of 4000 ppm to chicken feeds-Improves OTA-suppressed body weight gain
-Protection against OTA-induced suppression of humoral immune response
-Protection against OTA-induced kidney and liver damages
-Decreases OTA-induced rise in serum levels of uric acid and glucose
[212]
Tinospora cordifolia extract given at 100 mg/kg b.w. per day to mice for 12 days-Protection against OTA-induced changes in spleen and blood biochemistry in mice
-Antioxidative properties against OTA-induced oxidative stress
-Protection against genotoxic effect of OTA
[215,216]
Tinospora cordifolia at different doses in different animals or humans-Protection against liver damages
-Improves humoral and cellular immunity
[239,242,243,244,245]
Tinospora cordifolia extract in vitro study-Antioxidative properties[246]
Tinospora cordifolia extract given to mice at doses of 50–200 mg/kg b.w.per day-Protection against AFs-induced oxidative stress
-Protection against AFs-induced liver and kidney damages
[247]
Tinospora cordifolia at different doses in different animals or humans-Protection of gastrointestinal mucosa
-Protection against liver damages
-Improves humoral and cellular immunity
[248,249,250,251,252]
Tinospora cordifolia extract given to rats at dose of 250 mg/kg b.w.per day-Antidiabetic properties proven by suppression of alpha glucosidase activity[253,254]
Glycyrrhiza glabra extract in vitro study-Suppression of lipid peroxidation
-Antioxidative properties
[255,256,257]
Glycyrrhiza glabra extract given to mice at doses of 750–1500 mg/kg b.w.per day-Improves humoral and cellular immunity[258]
Glycyrrhiza glabra extract given at dose of 2000 mg/kg b.w./day to rats or 50–200 mg/kg b.w. day to rats -Hepatoprotective properties
-Antioxidative properties
-Decreases enzyme activities of ALT, ALP, and AST in serum
[224,259]
Glycyrrhiza glabra given at levels of 6600 ppm to chicken feeds-Improves OTA-suppressed body weight gain
-Decreases OTA-induced rise in serum enzyme levels of AST
-Protection against OTA-induced liver damages
-Protection against OTA-induced suppression of humoral immunity
[212]
Glycyrrhiza glabra given at different doses to rats-Protection of liver
-Lipid-lowering action
-Decrease cholesterol
-Inhibition of lipid peroxidation
[260]
Glycyrrhiza glabra at different doses in different animals-Antibacterial/antiviral properties
-Anti-inflammatory properties
-Anti-hyper glycemic properties
[261]
Polyherbal additive “Growell” given at 350 or 750 ppm to chicken feed-Protection against AFs- or OTA-provoked blood biochemical changes
-Protection against AFs- or OTA-provoked pathological changes in internal organs, e.g., liver, kidney, spleen, bursa of Fabricius, and thymus of broilers
[262,263]
B. refescens, A. leiocarpus, I. asarifolia, G. senegalensis and M. oleifera-Antioxidative properties[264]
Turmeric powder given at 400 ppm to chicken feed-Antioxidative properties in broilers
-Protection against AFB1-provoked increase in lipid peroxidation
-Decreases AFB1 contamination levels in liver of broilers up to undetectable levels
[265]
Vitamins or natural bio-substances
Phenylalanine given to mice, rats, or chicks at levels 20–25 ppm to the feeds-Improves OTA-induced suppression of body weight gain
-Improves OTA-induced suppression of eggs production
-Improves OTA-induced suppression of protein synthesis
-Protection against OTA-provoked kidney and liver damages
-Protection against OTA-provoked damages in lymphoid organs, e.g., spleen, bursa of Fabricius, and thymus
-Decreases OTA-induced rise in serum urea and creatinine
-Protection against OTA-provoked suppression of humoral immune response
-Protection against OTA-provoked carcinogenic effect in rats or chicks
-Protection against OTA-provoked teratogenic effect in mice
[6,10,11,14,15]
[209]
Citric acid addition to apple juice-Decreases content of PAT in apple juice[266]
Ascorbic acid and/or vitamin B addition in vivo or in vitro studies-Decreases content of PAT in apple juice[267,268,269,270]
Ascorbic acid addition at 300 ppm to the diet of laying hens-Protection against OTA-provoked decrease on egg production, eggs shell damages, and decrease in eggs’ weight [271,272]
Vitamin E supplementation at 200 ppm to the cockerels’ diet -Protection against OTA-provoked immunosuppression[218]
Ursolic acid-Protection against OTA-induced kidney damages
-Antioxidative properties against OTA-induced oxidative stress
-Reducing the apoptotic effect of OTA
-Protection against OTA-induced decrease in cell viability of human embryonic kidney 293T (HEK293T) cells
[273,274]
Oleanolic acid-Protection against OTA-induced kidney damages
-Amelioration of OTA-induced apoptotic damages
-Increased viability of OTA-treated HK-2 cells
[275]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Stoev, S.D. Biocontrol Agents and Natural Feed Supplements as a Safe and Cost-Effective Way for Preventing Health Ailments Provoked by Mycotoxins. Foods 2025, 14, 1960. https://doi.org/10.3390/foods14111960

AMA Style

Stoev SD. Biocontrol Agents and Natural Feed Supplements as a Safe and Cost-Effective Way for Preventing Health Ailments Provoked by Mycotoxins. Foods. 2025; 14(11):1960. https://doi.org/10.3390/foods14111960

Chicago/Turabian Style

Stoev, Stoycho D. 2025. "Biocontrol Agents and Natural Feed Supplements as a Safe and Cost-Effective Way for Preventing Health Ailments Provoked by Mycotoxins" Foods 14, no. 11: 1960. https://doi.org/10.3390/foods14111960

APA Style

Stoev, S. D. (2025). Biocontrol Agents and Natural Feed Supplements as a Safe and Cost-Effective Way for Preventing Health Ailments Provoked by Mycotoxins. Foods, 14(11), 1960. https://doi.org/10.3390/foods14111960

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop